,ticker,content
0,CAH,stock be lower tuesday morning earning report kick full swing dow jone industrial average fall most goldman sachs gs johnson johnson jnj weigh dow shed nasdaq composite be small cap russell give volume be higher board vs same time monday medical bank oil issue lead downside today stock market action airline food retail stock be few gainer dow stock be active component report earning ibm ibm be slate report close goldman sachs gap fall heavy volume month low big bank result miss view top bottom line share have be consolidate day move average past few week bank america bac rise nearly fast trade top quarterly view stock have also be consolidate week move average johnson johnson jnj drop gapping day line high turnover back buy point last base dow component drug medical device maker report earning beat revenue miss analyst target cardinal health cah gap plunge breaking day day line massive volume medical product distributor say buy medtronic mdt medical supply unit also guide full year earning estimate lower back dow unitedhealth group advanced healthy trade health insurer deliver result top consensus forecast boost full year outlook share be rebound day line related goldman sachs blame weak trading revenue politic bofa topsjohnson johnson earning top drug sale be drag
1,CAH,stock market ever find way major index tuesday continue pattern minor price movement provide only crumb guidance investor try figure next move nasdaq composite cut loss mix telecom software chip outperformance volume rise russell
2,CAH,share network ffiv citrix system ctxs lam research lrcx mattel mat mckesson mck fall late wednesday earning report be lead maker application delivery controller adcs electronic box direct datum traffic computer server fiscal earning rise share top forecast cent sale climb miss view give guidance line wall street target share fall late trading have close stock market today find support day line hit record high dec citrix be leader virtualization software boost server performance software rival hardware citrix earn share sale top consensus ep revenue company see gaap ep revenue be well consensus ep sale not clear number be comparable citrix guidance exclude gotomeeting be merge logmein logm company also hike buyback plan share fall late trading citrix rise regular session hit highest level march chip equipment maker lam research earn share beating view cent revenue exceed target lam research also give bullish guidance current quarter still lam share fall late trading close new time high drug distributor mckesson earn fiscal top estimate revenue rise nearly fall short view company do see fiscal ep vs analyst view mckesson also pay buy covermymed beef technology offering drugmaker insurer other mckesson share tumble abc cardinal health cah also sell sympathy mattel earn cent share critical holiday fourth quarter well view cent toy maker report sale miss forecast year earlier mattel lose late trading related qualcomm mixed la vegas sand miss view ebay meetswestern digital earning beat view follow seagate beat
3,CAH,cardinal health cah monday lower full year forecast due smaller margin key pharmaceutical sector report fiscal first quarter profit come ahead analyst estimate restore order drug wholesale sector share dublin ohio base company rise wake double digit sell friday wrought lower expect earning rival mckesson mck mckesson end friday carnage nearly try mount comeback monday rise third company drug distribution power triumvirate abc also get catch sell swirl lose more friday monday share climb plan release earning wednesday heel mckesson challenge last week cardinal result be downright bore thankfully evercoreisi analyst ross muken say note client add parenthetical phrase pharma distribution miss ebit forecast be expect be weaker originally anticipate fy magnitude cut be not frightening cardinal health say quarterly income be adjust earning be share surpass wall street expectation average estimate analyst survey zack investment research be earning share prescription drug distributor post revenue period ahead analyst survey zack expect ibd take cardinal health share take severe drubbing friday gapping drastically competitive concern expressed rival drug distributor mckesson further share have be trend reach intraday high april bright side major drug wholesaler cardinal drop friday be least drastic just cardinal however lower full year earning outlook range share previous guidance analyst poll thomson reuter expect full year ep top end cardinal new range company state segment be impact generic pharma pricing more significant factor unfavorably impact segment follow reduce level brand price inflation be unclear competitive environment citi analyst garen sarafian say note client associate press contribute report
4,CAH,share drug distribution giant mckesson mck go free fall friday morning drag main rival report fiscal second quarter earning be well short analyst estimate drastically lower full year forecast mckesson stock tumble nearly point end day end session chief rival drug distribution business cardinal health cah abc be double digit cardinal finished day share plunge note citi research analyst garen sarafian say mckesson be blame much trouble say have make move shore more business independent pharmacy have reason refute mckesson management respect find extremely odd peer raise rank company conservative culture nearly quarter century choose compete so aggressively create such large impact mckesson sarafian write san francisco base mckesson say adjust net income be share average estimate analyst survey zack investment research be earning share prescription drug distributor post revenue period also do not meet street forecast analyst survey zack expect ibd take mckesson stock have long be reliable climb steadily intraday peak have plunge then friday stock plummet put half peak value now rank third ibd medical wholesale drug supplier group now top mckesson lower full year earning forecast range share estimate thomson reuter have call earning share friday tumble mckesson share have fall nearly begin year standard poor index have increase slightly more mckesson cardinal health have virtual stranglehold drug distribution market collectively control well mckesson be biggest annual revenue more putt fifth spot fortune list be more cardinal be st more however exist razor thin margin often be less mckesson net income be nearly revenue quarter
5,CAH,come presidency donald trump certain prospect try unravel president obama affordable care act send share hospital stock cardiac arrest wednesday trading major insurer be mixed drug wholesaler enjoy revival most nation biggest hospital operator plunge double digit lead like tenet healthcare thc trouble community health system cyh tenet stock lose quarter value drop community plummet nation biggest hospital company hca holding hca fall nearly lifepoint health lpnt plunge universal health service uhs drop be paltry comparison still gouge nearly share bring hospital be expect take brunt expect drop federal health care funding demise aca commonly know obamacare leave million american uninsured unable pay hospitalization thus cut profit major health care facility operator mizuho security analyst sheryl skolnick ann hyne say note client trump victory republican manage retain control house senate do not bode well health care company gop triple play worst possible outcome health care stock be reality analyst say note client see extreme risk aca repeal replace loss medicaid expansion primary driver result hospital health plan reversal many value base regulation promote home health care insurer however be begin cut ty ambitious health coverage plan even trump surprise victory tuesday election so effect be mixed unitedhealth group unh share be fractionally aetna aet jump anthem antm be early swung gain close cigna ci share jump humana hum surge nearly seem carrier medicare heavy business be largely shield obamacare repercussion drug wholesaler revele trump election appear pharmaceutical company bask more pressure free environment now democrat hillary clinton have be dispatch clinton have vow combat exorbitant drug pricing mckesson mck fall sharply late last month disappointing earning report re-cover wednesday trading share surge close rapture extend main rival abc also jump more cardinal health cah climb nearly tp
6,CAH,teva pharmaceutical teva mylan myl endo pharmaceutical endp lannett lci other generic drug maker tumble thursday afternoon bloomberg report justice department be investigate possible price collusion charge likely year end doj be probe more dozen generic drug maker collude pricing accord bloomberg mylan issue follow statement mylan be have always be commit cooperate antitrust division investigation date know evidence mylan participate price fix teva pharmaceutical have disclose subpoena be cooperate bloomberg add lannett also have receive subpoena wall street journal say antitrust probe be year old cover dozen drug bloomberg say cite source grand jury be examine executive agree raise price teva share plunge stock market today fall lowest level november mylan lose lannett crash endo pharmaceutical akorn akrx taro pharmaceutical taro fall doj collusion probe news be latest sign drug industry face increase regulatory political pressure price hillary clinton have vow crack drug price former democratic rival bernie sander have hit specific drug stock negative tweet latest report hit more just drugmaker cvs health cvs drug store giant pharmacy benefit manager lose pure play pbm express script esrx sank drug distributor abc mckesson mck cardinal health cah fall nearly follow huge loss oct mckesson miss warn cite competitive pressure price mckesson lose nearly day cardinal nearly diplomat pharmacy dplo crash huge miss late wednesday price concession lower demand hepatitis drug
7,CAH,main index be volatile friday facebook fb google parent alphabet googl give nasdaq lift nasdaq quickly erased midday gain be alphabet rise strong volume add room buy point company beat estimate late thursday facebook be most active trading today market climb back buy point week old amazon com amzn big component nasdaq act drag online retailer gap day move average heavy volume miss profit expectation also fall dow jone industrial average be lower small cap russell be however volume be lower compare same time thursday ellie mae elli surge heavy volume be back buy point nearly extend entry support day move average be doubt thursday now look have work late thursday mortgage process software company beat expectation raise full year forecast medical stock be rout sector continue go bad earning season mckesson mck be single most heavily sell stock share volume time higher normal quarterly result miss estimate drug distributor sharply cut full year forecast pricing pressure peer cardinal health cah plunge sympathy fall lowest level abc plunge damage spread drug distribution industry generic drug biotech manage care medical service be health care industry group more bottom rung friday performance table abbvie abbv gap sharply volume more time average earning top view sale miss analyst target nordisk nvo gap lowest level november accelerate price deterioration start august drugmaker miss sale estimate cite decline sale price insulin related bottom line google cash machine amazon free spenderellie mae have track help mortgage lender go digital mckesson draghunt sector earning miss lower outlookabbvie topple humira miss sanofi diverge insulin panic
8,CAH,stock edge slightly higher first hour trading friday earning report continue roll investor weigh positive gdp datum dow jone industrial average climb nasdaq composite erased small open loss edge slightly higher russell hit hard prior session be volume be tracking lighter board stock market today vs same time thursday shoe apparel maker confectionary software stock be top gainer early trade internet retailer biotechs other medical stock lag drug distributor crash mckesson mck cardinal health cah abc plummet respectively mckesson quarterly result late thursday sharply miss estimate amazon com amzn gap slump fall day move average massive trade drop share be trading less high close thursday online retail giant report earning miss revenue meet view midpoint sale guidance come slightly consensus forecast alphabet googl rise more heavy volume result late thursday top view cost click decline miss analyst forecast share remain buy range flat base entry chevron cvx lead dow upside jump rise comfortably day line oil giant report earning beat revenue fall slightly short view volume be time usual pace integrate oil major be build new saucer base entry point rs line paint blue ibd chart have tilt slightly higher meaning now outperform exxon mobil xom gap fall day line also fast turnover result be also mixed earning fall less expect revenue slide more projection stock be work flat base buy point west texas intermediate crude future slide barrel ahead baker hughe weekly rig count due et economy expand annual rate accord commerce department forecast growth pace related amazon fall earning miss alphabet lumentum gigamon topeconomy grow best gdp gain year exxon profit top revenue miss chevron earning beat
9,CAH,stock be mixed friday morning investor digest commerce department positive read third quarter gdp growth several big earning reportsdow industrial remain slightly higher fall fractionally nasdaq lose big bone earning report power early action stock market today exception be baker hughe bhi oilfield equipment service heavyweight spiked news report general electric ge be discuss possible takeover houston company ge clarify be only discuss potential partnership not takeover ge share tick more amazon com amzn drop more surge third quarter earning stop well short view gain revenue increase meet expectation midpoint amazon fourth quarter guidance be just analyst target amazon end thursday buy range rebound week move average stock gap week move average break support alphabet googl rise more google parent report rise earning revenue gain expectation company also announce stock buyback initiative stock end thursday buy range flat base buy point have have trouble get lift level drug maker drug related stock be swing wildly sanofi sny hurtle ahead solid third quarter report include healthy increase full year earning guidance nordisk nvo plummet nearly lower guidance warning weaker insulin price drug distributor mckesson mck tank report big fiscal second quarter miss late thursday catch undertow fellow drug distribution giant cardinal health cah abc also tumble plunge cardinal swoon company report earning next week cirrus logic crus logged advance austin texas base chip maker report fiscal second quarter revenue earning far consensus expectation first profit gain quarters stock be form flat base buy point economy expand clip third quarter accord preliminary estimate commerce department be better double pace growth second quarter comfortably consensus view expansion price growth remain check gdp price index quarter jump second quarter line expectation labor department third quarter employment cost index rise equal second quarter advance line economist consensus target et university michigan report october consumer sentiment baker hughe report weekly rig count oil future hung lower west texas intermediate barrel gold reversed add ounce dollar slip vs euro yen bond fall lift year yield basis point overseas market be quietly mixed china lead index post minor loss friday tokyo nikkei add notch gain third advance past week stock europe be mixed cac paris edge afternoon trade frankfurt dax dip ftse london slip related amazon fall ep missfriday investing action plan exxon chevron netflix
10,CAH,be huge week earning apple aapl amazon amzn alphabet googl be list headliner slew industrial medical restaurant more also report tesla motor tsla report surprise profit qualcomm qcom buy nxp semiconductor nxpi nasdaq fall week amazon miss apple modest beat fail impress tech heavy index drop day line retake level last week sank dow rise bond continue fall world push year treasury yield multimonth high september quarter apple earn share year year sale analyst expect apple earn share sale holiday quarter apple guide wall street higher revenue profit margin outlook come short apple also unveil new macbook pro notebook computer feature touch screen strip application command shortcut replace function key apple fall week remain day line amazon report earning cent share big gain well short estimate cent commerce giant plow money amazon web service cloud compute unit big expansion fulfillment center head holiday season revenue rise meeting view aw be bright spot earning report revenue rise year year beating consensus revenue guidance also lag amazon share fall friday close day line first time month earning share item rise total revenue climb vs consensus estimate google parent alphabet signale higher investment cloud compute business higher marketing cost tie september launch pixel brand smartphone smart home speaker compete amazon echo google net revenue higher traffic acquisition cost tac cost be top view alphabet share nearly hit record high friday morning close day fractionally higher week fractionally lower still buy range tesla motor earn cent share exclude item soundly beating consensus estimate cent loss revenue climb top estimate elon musk have push tesla boost delivery turn profit analyst be skeptical effort be sustainable tesla maintain guidance vehicle delivery second half plan just tesla solarcity scty late friday be expect unveil integrate product offer solar panel battery storage charger tesla be process buy solarcity elon musk be top shareholder company well spacex tesla find resistance day line reversed end week cent solarcity climb gigamon gimo report third quarter profit revenue blow past estimate raise current quarter guidance santa clara calif base gigamon say ep item rise cent revenue jump analyst have project cent current quarter gigamon forecast ep cent revenue midpoint guidance vs consensus estimate cent profit revenue growth analyst say be new customer join mobile tmus gigamon shot friday hit record high intraday share have fall thursday day line lumentum lite say ep rise cent revenue climb top expectation current quarter revenue guidance be light telecom component shortage unnamed supplier ep guidance cent midpoint be consensus estimate cent lumentum fall late thursday report follow fall thursday acacia communication acia crash day week chinese telecom gear giant zte key acacia customer report weak revenue qualcomm announce deal buy nxp semiconductor create chipmaker revenue intel intc include debt deal be worth mobile communication chipmaker qualcomm say acquisition expand footprint key growth market include automotive internet thing security networking qualcomm nxp transaction mark biggest semiconductor deal ever surpass technology purchase broadcom avgo new oriental education technology edu meet fiscal ep view gain cent revenue climb analyst expectation enrollment boom ibd stock see revenue analyst guidance fellow chinese profit school stock tal education xrs result top estimate total student enrollment jump guide revenue wall street view new oriental stock rise more week blast base new high tal education climb also high related new oriental education break strong revenue guidancetal education stock enter profit take sell territory beatchipotle grill cmg earn cent share revenue fall nearly expect same store sale tumble fast casual burrito chain still struggle recover late food bear illness outbreak share fall wednesday hit year low panera bread pnra beat view send stock higher intraday wednesday reversed lower fall month low thursday buffalo wild wing bwld meet ep view miss sale share rise thursday recent lows food delivery service provider grubhub grub report ep rise revenue top grubhub active diner rise miss estimate slightly share have be month high fall nearly wednesday tumble day line biogen biib post sale ep ex item top view prod share nearly thursday bristol myer squibb bmy rise celgene celg alexion alxn beating earning amgen amgn late thursday beat share tumble nearly friday concern key drug enbrel go forward also friday nordisk nvo dive sanofi sny rise european drugmaker have different view outlook insulin treatment meanwhile drug distributor mckesson mck crash friday big miss blame rival abc heavy competition further pressure political attention drug price fall cardinal health cah nearly report earning next week related bristol myer celgene stock rocket sweeping top alzheimer datum vs eli lilly positivealexion crush expectation stock bound drug trial plansabiom abmd fall short earning send share tumble thursday edward lifescience ew revenue come light sale guidance also light send share plunge boston scientific bsx stock fall modestly ep meet sale top stryker syk narrowly top ep sale view late thursday send share friday third quarter gdp growth top forecast fastest growth year consumer spending growth slow significantly business investment remain weak real final sale exclude inventory gain next export slow separately durable good order edge lower core capital good demand fall most february boee ba say realistic possibility launch new midsize plane longer version max seek counter gain airbus eadsy boee result top analyst view revenue commercial airplane division fall defense revenue fall boee share rise week breaking base high related boee realistic possibility midsize jet stretch stock buy zonelockheed martin lmt top view defense giant raise full year outlook next production batch be split separate contract northrop grumman noc raise full year guidance report result analyst view send stock buy territory raytheon ep top estimate revenue be light patriot missile system maker improve guidance still fall short wall street view related lockheed soar outlook payout next contract see splitnorthrop stock enter buy range strong outlook beatbomb lift raytheon outlook be dud stock divesexxon mobil xom top ep estimate revenue fall well short capital spending fall oil production dip chevron cvx crushed ep view revenue miss slightly downstream profit be oil major refine margin weaken conocophillip cop loss wasn bad expect company raise full year production outlook lower capital spending guidance general electric ge be talk oil service firm baker hughe bhi partnership not purchase baker hughe break buy zone tuesday report better expect earning add friday industrial giant unite technology utx caterpillar cat mmm issue weak financial forecast global economic uncertainty hurt sector broadly general electric ge several other notable industrial firm already have cut guidance general motor gm meanwhile warn impact brexit plateau auto market strong full year ep guidance overall athletic apparel maker earning rise sale top view gross margin dip negative impact timing liquidation increase promotion foreign exchange rate armour ua see revenue growth consensus armour vow invest aggressively share fall more wee hit year low related armour dife growth target exec vow invest aggressively
11,CAH,stock market pare gain afternoon trading nasdaq go most critical test week composite lead rise less half intraday peak biotechs telecom other technology share be market leader today nasdaq be rise tentatively day move average continue bounce level give investor sense relief market have other obstacle not least be pile distribution day loss higher volume fall fractionally dow jone industrial average dip apple aapl climb give major index boost fact be highest increase component dow industrial midday volume be tracking lower board winner lead loser major exchange telecom sector finisar fnsr hit new high add more big volume stock gap strong earning report have not give back ground fiber optic company acacia communication acia reversed trade nearly other technology stock broadcom avgo climb back day move average rise more diversify chip firm also climb back cup handle buy point break past proper entry initially july pacific crest analyst praise broadcom other chipmaker say inventory be low head sale launch apple iphone friday accord medium report also pacific crest see little impact samsung electronic due recall galaxy note battery hazard medical stock come pressure notably major drug distributor mckesson mck abc cardinal health cah be heavy volume sank deeper correction oil price fall more energy department report surprise drop crude stockpile prior week increase domestic production energy stock be mainly lower related oil whipsaw supply fall output climb investment sinksmining fund sparkle gold rebound biotech fund build recent gainswhy apple new be bottom base
12,CAH,abc beat consensus view hike full year earning guidance tuesday rival drug distributor cardinal health cah warn profit decline current quarter share rise stock market today close day move average first time september cardinal health stock climb rebound day line now see adjust share earning prior outlook share current estimate share reaffirm guidance revenue growth pharmaceutical sourcing distribution service company expect profit growth midpoint update outlook sale growth slightly better overall market fiscal earning grow share revenue growth top estimate ep respectively pharmaceutical distribution revenue rise say company include revenue growth drug corporation segment thank solid organic sale growth include sale walgreen boot alliance wba pharmaceutical distribution revenue also include rise specialty group revenue most recent acquisition mwi veterinary supply pharmedium have make strong contribution specialty group deliver excellent performance say ceo steven colli statement renew relationship largest health system customer additional year have make progress effort address headwind face drug corporation ibd take pop key day line result tuesday have be trading day move average late june cardinal health be build cup shape base get closer entry point learn more identify basis buy ibd university meanwhile cardinal health say be project year year profit decline current quarter fiscal high single low double digit percent range due less incremental generic program contribution large customer loss pharmaceutical distribution segment analyst have expect rise share cardinal share earning revenue rise respectively slightly top view ep sale pharmaceutical segment sale rise medical segment sale grow fiscal expect pharmaceutical segment profit be essentially flat
13,CAH,weak trade europe early earning miss set tone tuesday stock index open moderately lower dow industrial backed nasdaq fall open personal spending rise june commerce department report same pace just consensus projection increase personal income growth be also flat vs view advance inflation remain check pce price index rise estimate gain core price energy food be also line estimate automaker be report july sale session host big name be active stock market moved open bell pfizer pfe drop open report earning massive drug distributor abc power peer cardinal health cah rise less earning report pharmacy chain cvs health cvs climb follow mixed second quarter performance diesel engine builder cummin cmi report result rise fraction cognex cgnx spiked open maker industrial inspection equipment turn board beat second quarter raise third quarter guidance well consensus viewssodastream international soda pop strong second quarter result ireland base drug maker mallinckrodt mnk bolt release solid fiscal third quarter result jump specialty drug brand offset weakness traditional generic drug stronghold salesforce com crm fall announce buy software maker quip stock deal value side integrate device technology idti topple report fiscal first quarter result line expectation late monday conference call management say loss key customer china base huawei technology lower quarterly revenue restaurant stock be take hard hit premarket trade texas roadhouse txrh shed mixed second quarter report late monday say same store sale have slow so far third quarter leaderboard stock have make slow progress buy point end monday extend just buy range chuy holding chuy fall stifel downgrade tex mex chain hold buy slash price target oil rebound more putt west texas intermediate back barrel brent crude just gold rise less ounce dollar swung lower year treasury yield tick basis point overseas china mainland market post thin gain weak trading tuesday hong kong stock exchange remain close due typhoon nida hong kong be expect resume trade wednesday japan tokyo nikkei slump first slip day europe market trade be early lows afternoon action cac paris frankfurt dax
14,CAH,health care service information provider mckesson be combine most technology solution arm specialist change healthcare form new business annual revenue company say joint statement tuesday new company establish more efficient suite end end payment claim solution well clinical capability unlock value technology solution business tax efficient manner say mckesson chief executive john hammergren mckesson change split ownership new company respectively hammergren be chairman neil crescenzo serve ceo newly form company be jointly govern mckesson change healthcare deal be see close first half calendar new company have commitment transaction related funded debt say mckesson change statement pay exist change debt mckesson change stockholder receive cash payment respectively meanwhile mckesson say separately be explore strategic alternative enterprise information solution business be part technology solution business be not merge change mckesson share close stock market today peer cardinal health cah rise abc add
15,CAH,biggest player global life science industry have be move cloud veeva system veev go public have be help get cloud base customer relationship management crm marketing project management solution roster client include amgen amgn biogen biib pfizer pfe merck mrk bayer bayry cardinal health ticker
16,CAH,last month forbe release annual fast tech list fastest grow public tech company veeva system veev come grubhub grub arista network anet facebook fb provider cloud base sale marketing software life science industry sport year annual ep growth rate year annual
17,CAH,apple aapl get price target cut early monday ambarella amba also get lower price target sluggish gopro gpro sale chipotle grill cmg get price target hike abbvie abbv be downgrade pacific crest lower price target apple maintain overweight rating stock cite weaker demand iphone apple share close stock market today ambarella price target be lower chardan capital market have neutral rating stock last week chipmaker post mixed result cut fiscal guidance weak sale wearable sport camera make gopro ambarella client share ambarella fall gopro rise chipotle price target be hike credit suisse have outperform rating stock recent poll find trouble burrito chain lose popularity younger customer last year fast food giant mcdonald mcd rise popularity chipotle tick higher drugmaker abbvie be downgrade buy goldman sachs have price target stock share add share micron technology mu fall monday be downgrade reduce neutral nomura security also lower price target hewlett packard enterprise hpe price target be raise maxim group rate stock hold share rise cardinal health cah be upgrade conviction buy buy goldman sachs share rally
18,CAH,twitter twtr tesla motor tsla get price target cut thursday follow earning report solarcity scty be downgrade cisco system csco be upgrade rbc capital market mizuho be several brokerage slash price target twitter rbc cut target mizuho lower target
19,CAH,mckesson mck monday cut fiscal earning share outlook see next year ep get hit cent cite weak generic drug price recent customer consolidation drug distributor grim forecast come rite aid rad mckesson have distribution deal agree last year be acquire walgreen boot alliance wba have distribution partnership abc merger cast doubt mckesson long relationship rite aid fiscal year end march mckesson now expect ep earlier forecast say profit be lower expect second half year analyst expect mckesson also expect fiscal ep growth forecast issue monday analyst expect growth company update guidance report result likely share gap finished lower stock market today rival fall cardinal health cah distributor fall walgreen end essentially unchanged rite aid dip cvs health cvs rise mckesson headwind also reflect expiration contract health service company optum transition contract elder health company omnicare target tgt mckesson expect current partnership rite aid continue end fiscal forecast signify considerable misstep company fbr analyst steven halper say note monday year mck have rarely have operational hiccup such core pharma segment write remain be see issue be temporary more structural nature company buy drug hold supply drugstore say be review administrative cost structure fourth quarter drug distributor profit hinge difference price manufacturer charge buy drug price charge selling drug retailer ep outlook do not include restructure review bring company say mckesson report third quarter earning jan follow bill peter twitter ibd_bpeter
20,CAH,hp hpq spinoff hewlett packard enterprise hpe get new analyst coverage tuesday drugmaker pfizer pfe top credit card firm visa have price target hike bernstein initiate hp outperform mizuho lower price target giant stock maintain neutral rating monday hp share pop nearly investor embraced company spinoff hewlett packard enterprise meanwhile hewlett packard enterprise be initiate neutral mizuho tuesday give price target hp share close thestock market today hewlett packard enterprise fall second day trading visa price target be raise rbc capital market maintain outperform rating stock monday visa fall short quarterly ep view also say be buy european counterpart visa europe much long anticipate cash stock deal share credit card giant rise tuesday pfizer fall even price target be raise argus have buy rating stock pfizer share rise monday follow positive article barron say big pharma firm strong pipeline drug be catalyst higher stock price fellow drugmaker valeant pharmaceutical vrx lose rbc capital market lower price target stock valeant have see steep drop share price ever short selling outfit citron research charge drugmaker fraud involve multiple specialty pharmacy valeant have deny allegation chipmaker nvidia nvda slide be downgrade hold buy needham cardinal health cah price target be hike rbc capital market fbr capital follow monday better expect quarterly earning report cardinal share rise tuesday add previous session red hat rht climb be upgrade buy deutsche bank software maker be near multiyear high set june ulta beauty ulta rise be initiate hold stifel follow vance cariaga twitter ibd_vcariaga
21,CAH,abc say tuesday have agree buy pharmedium healthcare holding clayton dubilier rice pharmaceutical sourcing distribution service company continue bulk business acquisition
22,CAH,privately hold pharmedium healthcare be national provider outsourced compound sterile preparation acute care hospital
23,CAH,be stranger acquisition earlier year buy animal health product distribution company mwi veterinary supply deal value
24,CAH,pharmedium acquisition be expect be cent cent accretive adjust net earning share fiscal be expect generate synergy fiscal company say press release
25,CAH,wall street didn seem impressed deal share close stock market today
26,CAH,pharmedium be provider customize outsourced csps meet specific hospital physician clinical need quality standard formulation be not otherwise commercially available accord press release serve hospital customer state
27,CAH,acquisition pharmedium strengthen core business meaningfully expand innovative service offering health system say ceo steven colli release
28,CAH,pharmedium be compelling addition business allow provide differentiate offering further increase ability drive value efficiency health system customer
29,CAH,transaction be subject regulatory review other customary close condition be expect close first quarter fiscal end dec
30,CAH,be ibd medical wholesale drug supplier industry group other large member group be mckesson mck andcardinal health cah abc say tuesday have agree buy pharmedium healthcare holding clayton dubilier rice pharmaceutical sourcing distribution service company continue bulk business acquisition privately hold pharmedium healthcare be national provider outsourced compound sterile preparation acute care hospital be stranger acquisition earlier year buy animal health product distribution company mwi veterinary supply deal value pharmedium acquisition be expect be cent cent accretive adjust net earning share fiscal be expect generate synergy fiscal company say press release wall street didn seem impressed deal share close stock market today pharmedium be provider customize outsourced csps meet specific hospital physician clinical need quality standard formulation be not otherwise commercially available accord press release serve hospital customer state acquisition pharmedium strengthen core business meaningfully expand innovative service offering health system say ceo steven colli release pharmedium be compelling addition business allow provide differentiate offering further increase ability drive value efficiency health system customer transaction be subject regulatory review other customary close condition be expect close first quarter fiscal end dec be ibd medical wholesale drug supplier industry group other large member group be mckesson mck andcardinal health cah
31,CAH,special report mutual fund strategy volatility stock market send investor scurry cover favor dividend be probably less likely panic select carefully dividend stock offer best world stock price performance steady payout so dividend fund be key component long term mutual fund investing here be
32,CAH,hot new technology widespread deadly disease whole lot money change hand be story last wednesday st jude medical stj agree pay cash thoratec thor developer implant call left ventricular assist device lvad help heart failure patient keep blood move lately be
33,CAH,health care service company cardinal health cah say friday acquire generic pharmaceutical distributor harvard drug group deal worth cardinal also offer earning guidance slightly ahead wall street view harvard drug bring revenue last year expand cardinal scale reach generic business acquisition also
34,CAH,straight quarters double digit sale growth straight quarters double digit earning growth prescription drug medical supply distributor mckesson be strongest financial run year
35,CAH,company continue generate robust sale thank key retail partnership favorable secular trend health care include increase demand medication age baby boomer generation
36,CAH,mckesson mck biggest trio major distributor dominate market partner pharmacy chain rite aid rad deliver drug manufacturer consumer retail outlet medical center
37,CAH,last year company announce new year agreement design create drug purchasing distribution efficiency deal run march mckesson assume responsibility sourcing brand generic medication
38,CAH,top line lift
39,CAH,agreement help mckesson post biggest revenue gain year fiscal end march company logged little more revenue year fiscal
40,CAH,mckesson abc cardinal health cah partner walgreen boot alliance wba cvs health cvs respectively control roughly fourth fifth drug distribution market
41,CAH,rite aid partnership provide mckesson massive scale purchasing power analyst say turn give sale volume pricing advantage enable grow revenue maintain favorable profit margin
42,CAH,mckesson be best position firm health care industry morningstar analyst vishnu lekraj tell ibd ve be very good performer
43,CAH,company also have partnership omnicare ocr provide pharmacy service long term care facility however bloomberg news have report omnicare have attract recent buyout interest express script hold esrx cvs health threaten mckesson relationship
44,CAH,fiscal fourth quarter mckesson wholesale drug distribution business drive sale grow year earlier exclude time item earning continue operation climb share
45,CAH,analyst poll thomson reuter expect full year earning rise fiscal year fiscal
46,CAH,mckesson stock price touch high currently trade stock be more
47,CAH,mckesson spokeswoman say executive be not available comment article conference chief financial officer james beer offer bullish outlook fiscal year ahead
48,CAH,be call continue growth strength right distribution solution business say
49,CAH,beer point solid generic drug price increase fiscal say higher price be increasingly important factor positive trend be case again
50,CAH,too soon gauge current fiscal year be strong front last year say generic price be still expect rise heighten demand drug treat wide array ailment
51,CAH,brand drug front beer say mckesson anticipate steady pricing volume growth year ahead several drug include treat hepatitis high cure rate be increasingly prescribe
52,CAH,strong price volume be important drug distributor buy medication manufacturer store then sell retail pharmacy other outlet
53,CAH,distributor profit spread wholesale price charge manufacturer retail price pharmacy set conjunction insurer
54,CAH,even drug price taper distributor still generate solid profit margin selling drug other product high volume
55,CAH,majority mckesson pharmaceutical distribution business be north america be push growth internationally buyout german drug distributor celesio help mckesson grow sale outside north america latest complete quarter
56,CAH,continue view mckesson best position company pharma supply chain believe generic drug purchasing celesio synergy capital deployment drive upside stock deutsche bank analyst george hill note june research report
57,CAH,cfo beer say conference more buyout be offing find attractive opportunity sensible price
58,CAH,june report barclay capital analyst eric percher say base talk mckesson management be clear priority percher suggest mckesson be most likely build celesio deal make europe international priority
59,CAH,similarly morningstar lekraj say acquisition particularly international one line celesio give mckesson add global purchasing power complement distribution operation
60,CAH,boomer boost
61,CAH,sam pappas ceo mystic asset management long time health care industry investor tell ibd population age develop part world include europe demand prescription drug increase
62,CAH,be particularly evident massive baby boomer generation say couple more american now cover health insurance wake obamacare rollout mean more person not only need medication more american be able afford
63,CAH,need health care include medication be only go continue increase pappas say
64,CAH,roughly american baby boomer generation born accord census datum
65,CAH,many have moved retirement pappas say have show propensity seek medication early often treat ailment cause age do remain active drife overall demand prescription drug
66,CAH,point sale growth prominent prescription drug distributor such mckesson lekraj say be better beneficiary trend health care overall straight quarters double digit sale growth straight quarters double digit earning growth prescription drug medical supply distributor mckesson be strongest financial run year company continue generate robust sale thank key retail partnership favorable secular trend health care include increase demand medication age baby boomer generation mckesson mck biggest trio major distributor dominate market partner pharmacy chain rite aid rad deliver drug manufacturer consumer retail outlet medical center last year company announce new year agreement design create drug purchasing distribution efficiency deal run march mckesson assume responsibility sourcing brand generic medication top line liftthe agreement help mckesson post biggest revenue gain year fiscal end march company logged little more revenue year fiscal mckesson abc cardinal health cah partner walgreen boot alliance wba cvs health cvs respectively control roughly fourth fifth drug distribution market rite aid partnership provide mckesson massive scale purchasing power analyst say turn give sale volume pricing advantage enable grow revenue maintain favorable profit margin mckesson be best position firm health care industry morningstar analyst vishnu lekraj tell ibd ve be very good performer company also have partnership omnicare ocr provide pharmacy service long term care facility however bloomberg news have report omnicare have attract recent buyout interest express script hold esrx cvs health threaten mckesson relationship fiscal fourth quarter mckesson wholesale drug distribution business drive sale grow year earlier exclude time item earning continue operation climb share analyst poll thomson reuter expect full year earning rise fiscal year fiscal mckesson stock price touch high currently trade stock be more mckesson spokeswoman say executive be not available comment article conference chief financial officer james beer offer bullish outlook fiscal year ahead be call continue growth strength right distribution solution business say beer point solid generic drug price increase fiscal say higher price be increasingly important factor positive trend be case again too soon gauge current fiscal year be strong front last year say generic price be still expect rise heighten demand drug treat wide array ailment brand drug front beer say mckesson anticipate steady pricing volume growth year ahead several drug include treat hepatitis high cure rate be increasingly prescribe strong price volume be important drug distributor buy medication manufacturer store then sell retail pharmacy other outlet distributor profit spread wholesale price charge manufacturer retail price pharmacy set conjunction insurer even drug price taper distributor still generate solid profit margin selling drug other product high volume majority mckesson pharmaceutical distribution business be north america be push growth internationally buyout german drug distributor celesio help mckesson grow sale outside north america latest complete quarter continue view mckesson best position company pharma supply chain believe generic drug purchasing celesio synergy capital deployment drive upside stock deutsche bank analyst george hill note june research report cfo beer say conference more buyout be offing find attractive opportunity sensible price june report barclay capital analyst eric percher say base talk mckesson management be clear priority percher suggest mckesson be most likely build celesio deal make europe international priority similarly morningstar lekraj say acquisition particularly international one line celesio give mckesson add global purchasing power complement distribution operation boomer boostsam pappas ceo mystic asset management long time health care industry investor tell ibd population age develop part world include europe demand prescription drug increase be particularly evident massive baby boomer generation say couple more american now cover health insurance wake obamacare rollout mean more person not only need medication more american be able afford need health care include medication be only go continue increase pappas say roughly american baby boomer generation born accord census datum many have moved retirement pappas say have show propensity seek medication early often treat ailment cause age do remain active drife overall demand prescription drug point sale growth prominent prescription drug distributor such mckesson lekraj say be better beneficiary trend health care overall
67,CAH,ibd stock abc jump new high drug distributor report view top quarterly result raise full year guidance now see adjust earning range share prior guidance analyst poll thomson reuter be expect expect full year revenue
68,CAH,striking game change deal year drug health supply distributor be prime add yet more ingredient growth formula range expansion animal health expect flurry new business generic version biologic drug abc ibd stock be largest global pharmaceutical distribution
69,CAH,march datum point strong month prescription drug sell stock supply chain be single thursday top idea drug supply chain report evercore isi single cvs health cvs drug distribution giant mckesson mck have buy rating attractive upside next month see numerous
70,CAH,cardinal health cah announce monday be buy johnson johnson jnj cardiology endovascular device business cash cardinal drug wholesaler look boost cardiovascular business say acquisition cordis boost earning cent share age population accompany demand less invasive medical
71,CAH,handful big company make big move tuesday several apple aapl chip supplier pharmaceutical distributor hit new close high
72,CAH,today screen day feature big cap leader generally top stock market value least price higher
73,CAH,technology avgo end day analyst expect singapore base firm announce biggest earning growth year report wednesday share earning be see rise same quarter last year have ibd composite rating mean have outperformed percent stock market
74,CAH,fellow iphone chipmaker skywork solution swks close day day line continue steadily upward march woburn mass base company also have composite rating boast year streak accelerate earning growth
75,CAH,taiwan semiconductor tsm close breaking flat base late january company chipmaker apple affiliation have composite rating quarters accelerate earning growth
76,CAH,drug distributor mckesson mck close well day line company latest earning report share be boost company acquisition german health care company celesio
77,CAH,abc stock break flat base back october have be climb reach end trading session chesterbrook penn base distributor also complete acquisition mwi veterinary supply tuesday
78,CAH,drugmaker have also earn highest possible ibd composite rating cardinal health cah control more distribution market
79,CAH,related
80,CAH,apple investor watch next big thing
81,CAH,drug distributor build strength era change
82,CAH,follow elaine low twitter ibd_elow handful big company make big move tuesday several apple aapl chip supplier pharmaceutical distributor hit new close high today screen day feature big cap leader generally top stock market value least price higher technology avgo end day analyst expect singapore base firm announce biggest earning growth year report wednesday share earning be see rise same quarter last year have ibd composite rating mean have outperformed percent stock market fellow iphone chipmaker skywork solution swks close day day line continue steadily upward march woburn mass base company also have composite rating boast year streak accelerate earning growth taiwan semiconductor tsm close breaking flat base late january company chipmaker apple affiliation have composite rating quarters accelerate earning growth drug distributor mckesson mck close well day line company latest earning report share be boost company acquisition german health care company celesio abc stock break flat base back october have be climb reach end trading session chesterbrook penn base distributor also complete acquisition mwi veterinary supply tuesday drugmaker have also earn highest possible ibd composite rating cardinal health cah control more distribution market related apple investor watch next big thingdrug distributor build strength era change follow elaine low twitter ibd_elow
83,CAH,most powerful middleman industry global economy be emerge more half decade difficult transition drug distributor purchase drug often entire line drug manufacturer warehouse sell retail chain mail order online specialty pharmacy well physician office clinic company dominate key piece
84,CAH,drug supplier occupy small corner medical sector performance past few month have be outstanding medical sector be rank friday monday lead drugmaker stock drug supplier subgroup doesn boast sector leader have easily outpaced
85,CAH,abc thursday top sale earning view fiscal fourth quarter help contract wag alliance boot provide brand generic pharmaceutical product earning rise top nickel mark fourth straight quarter accelerate earning growth revenue rise estimate
86,CAH,big drug distributor mckesson mck abc cardinal health cah see decent growth come quarters thank favorable macro trend include rise number insure american obamacare accord series new report rbc capital market
87,CAH,rbc analyst david francis initiate coverage stock outperform rating
88,CAH,writing drug distributor revenue market cap francis say utilization trend health care system be poise rebound very soft year period economic growth be finally gain traction affordable care act aka obamacare create environment greater number individual be cover insurance seek treatment
89,CAH,trend combine marginal generic price inflation see recent quarters have positive effect drug use benefit entire supply chain francis add
90,CAH,mckesson rank annual revenue market cap big cardinal rank market cap revenue combine control more drug distribution market
91,CAH,be due report result oct fourth quarter fiscal analyst poll thomson reuter expect log full year revenue fiscal be biggest gain least decade
92,CAH,contrast mckesson post fiscal revenue gain cardinal logged decline
93,CAH,stock be part ibd medical wholesale drug supply group rank industry ibd track be top stock group composite rating mckesson have composite rating cardinal rating be big drug distributor mckesson mck abc cardinal health cah see decent growth come quarters thank favorable macro trend include rise number insure american obamacare accord series new report rbc capital market rbc analyst david francis initiate coverage stock outperform rating writing drug distributor revenue market cap francis say utilization trend health care system be poise rebound very soft year period economic growth be finally gain traction affordable care act aka obamacare create environment greater number individual be cover insurance seek treatment trend combine marginal generic price inflation see recent quarters have positive effect drug use benefit entire supply chain francis add mckesson rank annual revenue market cap big cardinal rank market cap revenue combine control more drug distribution market be due report result oct fourth quarter fiscal analyst poll thomson reuter expect log full year revenue fiscal be biggest gain least decade contrast mckesson post fiscal revenue gain cardinal logged decline stock be part ibd medical wholesale drug supply group rank industry ibd track be top stock group composite rating mckesson have composite rating cardinal rating be
94,CAH,be nothing earth shake drug distributor decision change business strategy couple year simply decide go few big client rather pursue bunch smaller one today decision abc be poise post best annual financial performance year company distribute brand
95,CAH,stock future hold steady healthy gain ahead monday open market look short week preholiday trade dow future be level trading point fair market value
96,CAH,nasdaq future future be also steady point respectively
97,CAH,stock market today have work cut christmas week trade generally tend be light young uptrend run heavy distribution friday raise question long last
98,CAH,economic news isn likely have much impact chicago federal reserve national activity index most prominent piece economic news prior open show slip november accelerate october contraction be not economist consensus have expect increase
99,CAH,international market also appear have negligible effect stock europe trade modestly higher midday china market rise include jump shanghai composite tokyo nikkei japan slip
100,CAH,dollar rise bond edge oil price slip west texas intermediate bob barrel brent crude just most metal trade higher big gain
101,CAH,be star war effect early trade walt disney be stock lead dow better gain premarket trade goldman sachs gs apple aapl also gain more
102,CAH,disney star war force awaken gross estimate canada weekend be expectation beating prior record holder jurassic world gross premier june avenger pull premier
103,CAH,disney share briefly clear buy point cup handle base november then drop undercut buy point more trigger sell rule
104,CAH,huge screen savvy imax imax jump new star war film reportedly premier imax screen weekend pull set imax record top open weekend take jurassic world accord box office figure deadline hollywood imax ibd stock end friday buy point cup handle base
105,CAH,also ibd list arm armh perked ahead open share cambridge england base chip designer tumble last week end stock converge week line support stock future hold steady healthy gain ahead monday open market look short week preholiday trade dow future be level trading point fair market value nasdaq future future be also steady point respectively stock market today have work cut christmas week trade generally tend be light young uptrend run heavy distribution friday raise question long last economic news isn likely have much impact chicago federal reserve national activity index most prominent piece economic news prior open show slip november accelerate october contraction be not economist consensus have expect increase international market also appear have negligible effect stock europe trade modestly higher midday china market rise include jump shanghai composite tokyo nikkei japan slip dollar rise bond edge oil price slip west texas intermediate bob barrel brent crude just most metal trade higher big gain be star war effect early trade walt disney be stock lead dow better gain premarket trade goldman sachs gs apple aapl also gain more disney star war force awaken gross estimate canada weekend be expectation beating prior record holder jurassic world gross premier june avenger pull premier disney share briefly clear buy point cup handle base november then drop undercut buy point more trigger sell rule huge screen savvy imax imax jump new star war film reportedly premier imax screen weekend pull set imax record top open weekend take jurassic world accord box office figure deadline hollywood imax ibd stock end friday buy point cup handle base also ibd list arm armh perked ahead open share cambridge england base chip designer tumble last week end stock converge week line support
106,CAH,monday abc earn upgrade relative strength rs rating unique rating identify technical performance used worst best score indicate stock price performance last week match rest market history reveal market biggest winner tend have better rs rating early stage move be build flat base buy point see stock break volume least higher normal post earning growth most recent report sale growth come keep eye company next round number aug hold rank peer medical wholesale drug industry group cardinal health cah mckesson mck be also group highest rate stock related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
107,CAH,cardinal health cah report lower quarterly revenue eighth quarter row offer profit guidance come year largely miss analyst estimate drug distributor expect earning share fiscal midpoint consensus analyst poll thomson reuter cardinal fiscal fourth quarter earning share rise
108,CAH,disclose value merger acquisition venture capital backed company fall strong first quarter total deal have disclose value totale amount compare be strongest month period first quarter also have
109,CAH,just health care investor thought be safe dive back retail pharmacy stock amazon com amzn deliver jolt thursday buy pillpack online pharmacy deliver prescription presort dose move send share cvs health cvs walgreen boot alliance wba tumble drug distributor abc cardinal health cah mckesson mck also retreat pharmacy benefit manager express script esrx april walmart wmt have reportedly be close deal buy pillpack nudge aside amazon meanwhile amazon fear shake health care longer look quite so scary company shelved plan deliver medical supply now again be focus just big threat amazon represent prescription retail industry already cvs have moved same day delivery major market next day delivery cvs health walgreen be just add dow jone be develop new drugstore model deliver broader array medical service get newsletter deliver inbox more info product service privacy policy term immediate reaction be sell cvs stock sank walgreen stock fall stock market today amazon rise cardinal health mckesson lose respectively express script fall walmart slide health insurer also sell perhaps understandably aetna aet be be buy cvs health sank cigna ci be buy express script lose unitedhealth unh retreat earlier thursday walgreen boost dividend share buyback plan top earning expectation term amazon pillpack deal be expect close later year weren disclose get instant access more trading idea exclusive stock list ibd proprietary rating only also dow jone future try rally key tech sector flash big warningif want buy more apple nvidia share read thisstock market today track market trend best stock watch
110,CAH,stock rolled mixed open thursday disappointing first quarter gdp revision news amazon com amzn rattle pharmacy industry chip stock marvell technology mrvl soar china approve acquisition cavium cavm retail stock future be early pressure earning report bed bath bbby pier import pir retailer take additional heat pharmacy giant cvs health cvs new dow jone component walgreen boot alliance wba dive amazon announce buy online pharmacy service pillpack dow jone industrial average open lower walgreen dive nearly nasdaq composite trade less edge earning drive gain mccormick mkc accenture acn counter heavy loss walgreen cvs abc mckesson mck commerce department revise first quarter gdp estimate lower growth be consensus projection growth hold steady gdp price index key inflation gauge rise be well expectation also change read consumer spending estimate be unchanged growth line expectation upshot growth be slower expect quarter inflation rise faster forecast complicate pressure federal reserve have signale more interest rate hike be likely end year be already wrestling impact finance stock market get newsletter deliver inbox more info product service privacy policy term trade brawl china world other largest economy be relatively quiet early thursday white house have backed away wednesday early threat use executive privilege order curtail investment china own company technology white house attempt appease beij investor fear be meet part way china thursday regulator approve marvell cavium merger hong kong hang seng index rise market feel bottom bit less june shanghai composite drop diving new bear market low tack sixth straight weekly decline japan tokyo nikkei continue trade flat just day line support day line stock europe fall mixed trade steep loss afternoon action frankfurt dax dive cac paris trade lower london ftse ditch early gain fall oil price tick fraction lower early thursday west texas intermediate trading just barrel oil price punch month high wednesday tight weekly supply datum add list element generate upward pressure oil stock post top advance wednesday ahead thursday open marathon petroleum mpc advanced findlay ohio base refiner be look stem week decline chip stock suffer further damage wednesday selling receive positive news early thursday marvell technology spiked cavium leap announce chinese regulator have approve marvell bid acquire datum center networking specialist marvell share be break support month base effort cavium be testing support week line month base company first announce deal november retail stock come sharp pressure amazon announce buy online pharmacy service pillpack undisclosed amount term deal be not disclose news report say walmart wmt have attempt acquire pillpack less move be amazon first major health service sector move january announcement have launch joint venture berkshire hathaway brka jpmorgan jpm create more effective efficient health service program company employee cvs health tumble nearly early action stock be march attempt retake support week move average year downtrend walgreen boot alliance drilled lower pharmacy chain report early thursday fiscal third quarter sale earning top analyst target management raise company quarterly dividend add stock buyback effort drug distributor also fall hard crumble mckesson swoon cardinal health cah tumble lower amazon share rise left ibd leaderboard stock still buy range buy point other retail stock be already early pressure handful earning report pier import dive weak guidance trump first quarter sale earning beat bed bath also fall hard more dip same store sale soured otherwise positive fiscal first quarter report get instant access more trading idea exclusive stock list ibd proprietary rating only also dow jone future key tech sector flash big big picture nasdaq stormy price action be desperate trump be avoid china trade warmillennial investor love stock robinhood top holdingsibd stock day apple oil near new buy point bullish pattern
111,CAH,investor be run exit anticipation federal action drug company blame opioid crisis drug distributor include cardinal health cah abc mckesson mck extend loss second day president donald trump pledge lower drug price very substantially not so distant future say justice department be consider major federal litigation company involved crisis trump threaten get tough drug dealer include used death penalty certain case speaking yesterday new hampshire state hardest hit opioid addiction justice department decide early april join local government sue maker opioid painkiller endo international endp share plunge much tuesday be be investigate various state opioid distributor be investigate include cardinal health mckesson much be unclear possible suit distributor however stock clearly seem be trend hyper sensitively evercore analyst ross muken cover drug distributor write note be possible be party proceed join file lawsuit base trump also reiterate promise lower drug price health human service secretary alex azar say agency be roll proposal month plan aim seek discount drug middleman include pharmacy benefit manager such express script esrx cvs health cvs caremark unitedhealth unh optumrx be interested biotech flirt battle opioid makerswal mart offer pill disposal product curb opioid abuseopioid crisis be time larger thought report say
112,CAH,stock index be mixed friday afternoon bounce afternoon lows president trump unveil plan cut drug cost nasdaq composite be be fraction dow jone industrial average gain small cap be flat also dow transport surge apparently get help drop oil price volume be tracking lower compare same time thursday advancer have small advantage decliner nasdaq nyse update story other market coverage visit stock market today president trump announce program aim lower drug price include measure increase competition get newsletter deliver inbox more info product service privacy policy term usedrug distributor stock fall trump unveil detail soon rally back mckesson mck erased loss be afternoon trading abc cardinal health cah erased loss be roughly stock have be lag month however market see real threat pharmaceutical industry sector lead market spdr pharmaceutical xph ishare nasdaq biotech ibb be ibd ethical drug industry group be third best day generic drug group climb biotechs rise technology sector see big move earning report nvidia nvda give back minor piece rally previous several day hold buy point double bottom base chip company beat sale profit view thank partly demand chip used mining cryptocurrency dropbox dbx share be volatile session company report adjust first quarter profit revenue beat expectation first post ipo earning report file sharing storage company go public share march have be most heavily trade new issue daily volume averaged more wednesday today trading ibd tal education tal try break past buy point base base pattern sputtering action shouldn be much surprise base be quite late stage tal chinese tutor education service provider have make amazing run november have form clear least basis then further gain be harder produce diamondback energy fang be rapidly give back territory be now nearly buy point cup handle earlier week friday diamondback fall day move average share rebound level be further compromise related here trump impact biopharma drug pricing speechnvidia forecast big drop cryptocurrency chip salessymantec plunge outlook disclose internal probe finance
113,CAH,amazon amzn have shelved plan become wholesale distributor prescription drug due cost complexity cnbc report news lit fire share beaten drug retailer distributor cvs health cvs shot walgreen boot alliance wba jump stock market today be session high drug distributor mckesson mck rise abc cardinal health cah amazon share didn react negatively news rise monday get newsletter deliver inbox more info product service privacy policy term report seem have most direct connection trio major drug distributor handle logistic major drug manufacturer big revenue low margin business complexity such handle temperature sensitive product lack interest hospital switch purchasing relationship keep amazon business investor seem interpret move decrease likelihood amazon enter retail prescription business give boost cvs walgreen so then amazon investor apparently don think internet retail giant need prescription drug keep customer loyalty amazon still enter prescription business such acquisition walgreen start small just online pharmacy meanwhile walmart wmt appear be increasingly focuse health care pharmacy key boost sale loyalty walmart be reportedly talk merge deepen partnership humana hum manage care business be focuse medicare population share walmart climb didn see much uptick amazon news break cigna ci manage care provider be buy pharmacy benefit manager express script esrx rise share unitedhealth unh largest manage care provider rise unitedhealth report open tuesday be interested unitedhealth lam research ibm goldman unite airline earning due investing action planapple stock face sell news reaction quarterly earningsmarket uptrend feature leader set upwhat do ibd stock have common netflix nvidia grubhub look best stock buy watch start step routinestock market today track market trend best stock watch
114,CAH,stock close broadly higher monday dow jone industrial average come bit short reclaim day move average netflix nflx rise close company announce result dow climb end slightly day move average get back trend indicator be positive sign market continue climb bottom signal week also close just day line nasdaq composite be small cap russell climb volume be higher nasdaq nearly flat nyse compare same time friday winner lead loser ratio nyse nasdaq netflix share rise close company earning share be extend find support pullback day move average video stream company report quarterly earning company earn cent share line view subscriber growth be strong amazon com amzn be drop plan sell drug hospital cnbc report news cause drug distributor stock rally mckesson mck jump trade back day move average cardinal health cah rise bounce month low drugstore medical wholesale supply medical product distributor stock also be monday top industry group afternoon trading amazon com share be continue trade day move average transportation sector continue lead logistic trucking truck manufacturing top industry group today market hunt jbht jump heavy trading company beat profit expectation earlier today stock climb back day move average be form base buy point bank continue earning announcement bank america bac beating first quarter earning morning earning rise cent share adjust revenue rise nearly analyst have expect cent revenue stock erased loss be more close defense contractor unite technology utx rise raytheon rtn northrop grumman noc raytheon climb buy point flat base volume be fading northrop be form base buy point boee ba be defense contractor have be see increase interest late friday france britain launch coordinate strike syrian chemical weapon facility accuse syrium used such weapon civilian breakout monday proofpoint pfpt rise past buy point flat base volume be weak proofpoint be several cybersecurity stock rise monday industry conference get underway analyst speculate buyout company cal maine food calm break volume more average share egg producer top buy point cup handle base close bit entry cal maine have be profitable past quarters post loss past quarters sale have rebound sharply february end quarter several optical stock slide commerce department bar chinese company import official say firm illegally ship equipment iran north korea lumentum lite tumble oclaro oclr acacia communication acia finisar fnsr stock be ibd fiber optic industry group have rebound group only lumentum have ibd composite rating related charle schwab beat ahead top rate trade interactive brokersbank america earning jump stock set upoption trading earning expectation high netflix alcoa atlassianstock drop market ignore good news earning
115,CAH,abc soar tuesday morning overnight report drugstore chain walgreen boot alliance wba seek acquire drug distributor also roil broader health care supply sector be word amazon com amzn be look turn medical supply business major supplier hospital outpatient clinic rival mckesson mck cardinal health cah fall tuesday morning medical supplier owen minor omi tumble stock market today share vault hit earlier walgreen boot alliance already own dip walgreen deal follow big venture health care sector late drug store pharmacy benefit manager cvs health cvs strike deal acquire health insurance giant aetna aet move be see pre emptive strike amazon january amazon team jpmorgan chase jpm berkshire hathaway brkb work lower health care cost employee ibd take stock market flux more important ever investor stay step market latest market analysis be sure read big picture regard medical supply amazon have meet hospital executive several time recently explore become bigger player field wall street journal report tuesday cite unnamed executive attend meeting mckesson lose cardinal health tumble be unclear mckesson cardinal health be react walgreen amerisoure buzz amazon report amazon report clearly seem impact medical supply firm owen minor give make new low henry schein hsic tumble patterson pdco drop amazon rise be interested amazon health care disruption fear clash realitycvs re go deliver amazon jpmorgan berkshire seek doamazon berkshire hathaway jpmorgan chase team health care cvs unitedhealth dive
116,CAH,important metric look stock be higher relative strength rating abc now clear threshold jump tuesday exclusive rating investor business daily track share price action worst best score grade show stock price movement trail week hold other stock database year market history show best stock typically have higher rs rating launch biggest price move see ibd help make more money be now consider extend buy range clear buy point first stage cup handle see stock form new pattern follow buy opportunity week tight pullback day week move average top bottom line growth moved higher last quarter earning be compare prior report revenue increase hold rank peer medical wholesale drug industry group cardinal health cah mckesson mck be also group highest rate stock related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
117,CAH,joseph papa have be ceo generic drug maker perrigo co just few week learn potential tiny metal fragment batch pill be november well oversaw triple revenue year sprint perrigo prgo
118,CAH,consider name put watch list look stock higher rs rating abc be stock just reach mark now earn score ibd unique rs rating identify market leadership used worst best score indicate stock price performance last week match other publicly trade company year market history reveal stock go make biggest gain tend have rs rating launch biggest price move look winning stock try simple have moved more past entry first stage cup handle meaning now proper buy range look stock create new chance pick share week tight pullback day week line earning grow last quarter prior report revenue also increase company hold rank peer medical wholesale drug industry group mckesson mck cardinal health cah be also group highest rate stock related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
119,CAH,index dow jone industrial average nasdaq composite continue rebound rise inflation pressure treasury yield trigger shift market correction confirm uptrend cisco system csco report strong earning weibo wb other china internet well several other top rate tech stock top rate hotel be mixed report chipotle grill cmg hire taco chief be next ceo facebook fb show sign lose more young user snap snap own plunge prior week index dow jone nasdaq composite surge latest week shrug rise price continue rise treasury yield market be back uptrend cisco hit year high bevy good news shopify shop hubspot hub weibo wb also have good result arista network anet logmein logm fall friday guidance cisco system csco announce stock buyback top earning forecast report first revenue gain quarters guide march quarter view higher aside new buyback cisco plan use repatriate cash dividend hike cisco have include domestic cash hand acquisition cisco share rise year high track top stock market trend free ibd network handily beat earning view jump revenue only edge estimate sale outlook march quarter disappoint share dive friday run past year management forecast sequential revenue decline march quarter mid point revenue guidance imply growth just estimate analyst say arista set expectation mid revenue growth be street guidance reflect stiffer competition cisco shopify shop earn cent share profit year earlier vs estimate cent revenue jump top consensus estimate commerce software firm forecast revenue expectation share edge thursday surge record high ahead earning shopify surge thursday related new america shopify be kill make business onlinefacebook fb be lose younger user snap snap own snapchat even faster pace previously expect say research firm emarketer say facebook be still add monthly user overall older age group be mainly responsible increase facebook lose user year snapchat add emarketer predict facebook instagram still add teen young adult share china internet company weibo wb parent sina sina report fourth quarter result largely top estimate weibo be social medium company have twitter twtr platform sina offer popular internet portal internet search leader baidu bidu also jump fourth quarter report top view thank upside online video news feed advertising related top china name be try form energy fang occidental petroleum oxy report result wall street estimate plan boost production year international energy agency say crude output overtake saudi arabia soon catch russia end year energy information administration say domestic oil production edge barrel day prior week opec see global demand growth increase bpd expect production growth outpace demand growth saudi arabia call production cut opec russia continue stock market revival weak dollar help lift crude barrel consumer price index core cpi rise more expect push year treasury hit fresh year high core inflation be still just market price greater certainty federal reserve rate hike still only chance fourth hike meanwhile january retail sale fall lead economist mark expectation first quarter gdp growth bitcoin continue upward trajectory move just briefly undercut mark prior week meanwhile litecoin vault anticipation build launch payment processor litepay upcoming fork blockchain meanwhile ibm ibm warn congress overregulating digital currency case have unintended consequence blockchain technology logmein logm report adjust earning beat estimate pro revenue top view logmein forecast profit share well estimate share march quarter full year revenue outlook be bit light logmein sell xively internet thing business web connect device google logmein complete reverse merger gotomeeting business citrix ctxs feb share have break earlier week fall friday undercut buy point chipotle grill say brian niccol ceo taco bell become fast casual chain chief executive march share sprint higher hope niccol know help bring hit nacho fry doritos loco taco taco bell menu revive chipotle sale traffic follow food safety issue meanwhile restaurant brand international qsr say burger king turn strong sale company more double dividend shake shack shak say plan more double store count last year level result beat view shake shack tumble friday guidance wyndham worldwide wyn marriott international mar hilton hlt hyatt report quarterly result top expectation hubspot hub swung fourth quarter profit revenue jump web marketing softward firm give march quarter full year guidance estimate cfo john kinzer leave end share shot ringcentral rng earn cent share revenue rise vs estimate cent cloud base business communication software maker forecast adjust earning well expectation ringcentral leap general dynamic gd buy defense contractor csra csra assume debt military contractor look increase service defense department wake increase defense spending solaredge sedg share vault report fourth quarter earning beat guide materially consensus estimate sunpower share fall disappointing earning first quarter revenue outlook expectation netapp ntap beat quarterly earning beat view give commentary imply reduction gross margin netapp fall thursday friday close week fraction share cybersecurity firm qualys qlys mimecast mime climb better expect earning qualys forecast march quarter profit view company be investing product marketing sale capacity mimecast email security specialist up fiscal revenue guidance cyberark cybr top revenue ep view close larger deal cyberark forecast line march quarter sale ep estimate chip gear maker apply material amat deliver better expect fiscal first quarter sale earning guide estimate higher current quarter double quarterly dividend announce new share repurchase plan share rise more week universal display oled provider technology material oled display sign new long term supply license agreement major customer samsung share rise groupon grpn see ep rise cent fourth quarter miss estimate revenue fall beating view gross billing slip stock sank martin marietta material mlm stock be ultimately close fraction higher build supply giant outperformed earning expectation tuesday coca cola ko report better expect profit sale pepsico pep also top view thank sale spike frito lay unit abc surge report walgreen boot alliance wba buy rest drug distributor doesn already own industry peer mckesson mck cardinal health cah owen minor omi drop word amazon amzn seek become major medical supplier hospital cbs cbs notch profit growth share revenue rise say have nearly stream subscriber share fall friday follow earning find resistance day still advanced week sport apparel footwear maker armour uaa record break even earning revenue growth vs view penny share stock race higher retake day move average week be interested stock buy watch top ipos big small cap growth stockslooking best stock buy watch start here
120,CAH,relative strength rs rating abc enter new percentile thursday rise ibd proprietary rs rating measure market leadership show stock price action last week measure other stock database decade market research show market biggest winner tend have rs rating north begin biggest run look best stock buy watch start be now consider extend buy range clear buy point first stage cup handle see stock form new pattern follow buy opportunity week tight pullback day week line earning grow last quarter prior report revenue also increase earn rank peer medical wholesale drug industry group mckesson mck cardinal health cah be also group highest rate stock related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
121,CAH,stock slip tuesday start bell threaten put damper market day bounce strong early move abc handful china base stock dow jone industrial average nasdaq composite open global stock china market picked rally retook lose ground ahead lunar new year holiday begin friday hong kong hang seng index pop shanghai composite rally shanghai exchange close thursday wednesday hong kong exchange be close friday monday japan tokyo stock exchange reopen monday holiday nikkei stumbling europe market remain mixed afternoon trade frankfurt dax cac paris be respectively london ftse hold gain dow microsoft msft drop head early downside share have be find support week line just clear flat base december apple aapl edge stock retook day line powerful rally monday have be struggle regain hold psychologically important level support feb mega cap mmm take early lead dow jone stock rise stock be look add third day rebound support day move average medical system supply name post deepest loss stock amazon com amzn announce plan expand medical supply business hospital supply chain henry schein hsic dive patterson pdco drop more open trade
122,CAH,vertex pharmaceutical snap top nasdaq food drug administration approve company symdeko treat cystic fibrosis vertex say begin shipping drug week vertex share have pull back more buy point trigger automatic sell rule share have be testing support week move average drug wholesaler spiked premarket action news report say company be talk walgreen boot alliance wba regard possible takeover walgreen own company hold market capitalization more market sell have pull back buy point trigger automatic sell rule stock open back entry tuesday market correction mean move be not valid walgreen share rise early trade share be trading deep yearlong consolidation competitor cardinal health cah mckesson mck drop respectively early trade armour uaa grab gain mixed fourth quarter report revenue come stronger expect share end monday november low september peak china base name be early leader ibd name weibo wb board fourth quarter beat weibo share be testing support week move average fall more buy point trigger automatic sell rule sina sina rolled ahead generally strong fourth quarter report sina hold control stake weibo also fall more cup base buy point make also subject automatic sell rule vipshop hold vip swung higher online retailer turn fourth quarter report late monday top analyst earning revenue target raise first quarter revenue guidance expectation crude oil trade lower post gain monday just enough snap day downtrend benchmark crude be early action trading barrel other commodity natural gas pop look rebound fall hard recent session copper rise more nearly post gain monday dollar pull back euro slip month low vs yen bond gain ground trimming year yield basis point bitcoin slip monday high bitcoin blockchain related stock be generally quiet also be interested big picture stock jump again hurdle remainwhy stock market sell do nowthese defense stock stand market correctionnike microsoft lead dow stock hold market correction
123,CAH,good economy have odd effect sink monday concern higher price borrow cost central bank remove crutch intend support rebound abroad individual company index quarterly result more granular measure customer attitude main driver stock be surpass wall street forecast particularly high rate not see previous decade bar result have be help ever tech health care financial include amazon amzn intel intc unitedhealth unh mastercard company dowdupont dwdp eastman chemical emn have lead supplier material higher industrial long ailing general electric ge also look solid long drought company have report quarterly result so far earning season top wall street estimate accord thomson reuter datum release thursday percent beat estimate revenue best rate estimate earning third quarter accord thompson reuter sale best least earning be currently track deliver gain revenue robust assume remain company due report meet estimate analyst also appear optimistic first quarter earning even prospect higher wage touch investor fear inflation economic growth stir anxiety federal reserve be more aggressive raise interest rate keep growth honest ibd take thursday feb market action friday monday market drubbing ibd change market outlook uptrend pressure confirm uptrend equivalent green light turn yellow make sure read big picture column day stay top market prevailing trend so ll know make sense be aggressive move sideline still global recovery have bring new demand technology energy infrastructure rebound oil price have boost demand equipment kind lift industrial turn demand supplier chemical material stock market today index dow industrial nasdaq composite sell yet again treasury yield hit multiyear high stock rally strongly start part expectation strong broad earning growth thomson reuter material sector include company dowdupont eastman company have beat earning most recent quarter highest percentage industry sector measure firm percent company material segment have beat revenue even trouble deepen general electric have weigh growth industrial sector try focus more aviation power health care segment overall have remain solid percent have beat earning revenue ge earning share slide fourth quarter face sec investigation analyst say company be remove dow technology sector technology company have beaten earning estimate lead company advanced micro device amd intel intc xilinx xlnx percent beat revenue strong growth semiconductor semiconductor equipment more tech company be also bring bigger business consumer re see transition consumer base business base be big driver aurelio say so re see thing datum center growth consumer discretionary category quarters company have produce bar result amazon amzn last week turn earning far ahead analyst expectation help gop new tax law broader migration commerce smart device projection alexa be very optimistic far exceed ceo jeff bezos say statement time don see positive surprise magnitude very often expect double earning company thomson reuter health care segment include biotech pharmaceutical health care service come analyst view beat revenue unitedhealth nation largest health insurer be company surpass earning estimate widest margin be pharma distributor cardinal health cah resm rmd align technology algn maker invisalign dental brace earning follow bmo analyst matt borsch follow manage care company hospital other care provider characterize mediocre term volume number inpatient admission outpatient procedure doctor emergency room visit more volume say have be packed end fourth quarter more person meet deductible high deductible plan have become increasingly common have high deductible health plan generally have pretty strong dynamic person average increase utilization significantly ve meet deductible therefore be see more late year say company have report so far largely aren benefit low expectation expectation have remain relatively similar earning quarter compare quarters past be tad higher revenue aurelio say investor make way fourth quarter result market volatility outlook first quarter remain not so bad typically get closer next earning season expectation decrease aurelio say so see growth rate normally drop be go begin year say expectation be earning growth first quarter thursday growth expectation be lower guidance apple aapl many iphone chip supplier so pretty bullish signal say be interested big picture stock repeat bear sell big wage gain sink stock bond reason doubt datadid congress trump just crush stock market rebound brokerage receive fresh lift tax reform rate hike obamacare exchange enrollment show surprise gain trump attack
124,CAH,relative strength rs rating abc jump new percentile friday rise unique rating track technical performance show stock price action last week measure other stock database year market history reveal best perform stock tend have higher rs rating launch biggest run look winning stock try simple be now consider extend buy range clear buy point first stage cup handle see stock form new pattern follow buy opportunity week tight pullback day week move average post earning growth latest quarterly report sale rise company earn rank peer medical wholesale drug industry group mckesson mck cardinal health cah be also group highest rate stock related stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
125,CAH,sell health stock tuesday joint venture amazon com amzn jpmorgan chase jpm berkshire hathaway brkb wring cost saving health care system appear very unlikely impact industry earning next couple year accord analyst figure rein health cost participation big health care player look impossible task needham analyst kevin caliendo say note cost implement system adjudicate patient datum partner hospital doctor pharmacy national basis be onerous caliendo add scale big new partner wouldn be big enough squeeze discount provider steering patient way compare purchasing power unitedhealth unh cvs health cvs aetna aet anthem antm new company have align other provider way provide best care employee caliendo conclude fact caliendo give cvs big vote confidence earlier tuesday say plan combination aetna position create saving government private employer needham raise rating cvs strong buy target caliendo do think profit industry especially underwriting level be excessive be improvement current care delivery model be make see prime reason cvs aetna deal cvs be look shift more health care service lowest cost location store clinic different take unitedhealth playbook expand urgent care other outpatient locale drive saving customer such path forward be evident announcement amazon jpmorgan berkshire plan establish independent company be early plan stage accord statement trio group do not come problem answer acknowledge berkshire ceo warren buffett success be go require talented expert beginner mind long term orientation say amazon jeff bezos yet unclear point talented expert be wall street weigh long term nature effort dearth substantive detail initial shock wave ripple wall street subside share dow jone industrial average component unitedhealth nation largest insurer sank stock market today diving much earlier cvs health be process buy aetna pare loss drop drug distributor cardinal health cah mckesson mck be respectively prescription benefit management firm express script esrx sank have tumble earlier cvs unitedhealth also operate pbms manage prescription side health insurance contract pharmaceutical biotech stock also lose ground hit didn look much broader market downdraft tuesday merck mrk shed allergan agn gilead science gild pfizer pfe lose top earning view offer bullish guidance ibd take unitedhealth be rank ibd medical manage care industry group base earning sale margin stock performance trend visit ibd stock checkup see leader category insurer have be solid performer rank group long current confirm uptrend equivalent green light stay place lead stock lead group break buy point be more likely not have wind back here good place start look stock be poise move higher knee jerk reaction investor be surely reflection unsustainably high cost health care fact amazon have be itch disrupt retail prescription business be attach effort traditionally fear health care investor have be government not private sector impose cost control get handle runaway budget deficit thin industry profit process medicare negotiating drug cost be such fear industry expert say government be unlikely produce much way saving be willing deny patient access certain drug create political backlash amazon jpmorgan berkshire aren first big employer join force attack health cost leerink analyst ana gupte note tuesday health transformation alliance group large self insure employer launch last year also hope find saving improve employee satisfaction work cvs unitedhealth achieve aim initial report indicated alliance member expect save combine prescription cost year amazon jpmorgan berkshire say initial focus be technology solution provide employee family simplified high quality transparent healthcare reasonable cost new corporate entity say be free profit make incentive constraint just form technology solution take be far clear caliendo suppose berkshire bring underwriting skill ve never underwritten healthcare amzn make pharmacy medical procurement contribution provide expertise leerkink gupte say unclear amazon wading deeper solve health care mess accelerate move supply chain prescription industry also be interested trump state union move market downstock fall market show sign be ready breakgrubhub redhat lead ibd stock buy invest stock free new apps aim invest stock market start simple routine
126,CAH,relative strength rs rating abc climb higher percentile tuesday get lift exclusive rating investor business daily measure market leadership worst best score score show stock price behavior trail week compare other stock database history show best stock often have rs rating least begin largest climb see continue show renew price strength hit benchmark see ibd help make more money be trading buy range clear buy point cup handle proper buy range extend initial entry once stock hit benchmark best set buy opportunity show ep growth most recent report sale growth come look next report jan earn rank peer medical wholesale drug industry group mckesson mck cardinal health cah be also group highest rate stock related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
127,CAH,abc have relative strength rs rating upgrade wednesday welcome improvement still shy higher score prefer see proprietary rating track market leadership used worst best score show stock price performance last week compare rest market decade market research show best stock typically have rs rating north begin largest climb see continue show renew price strength hit benchmark look best stock buy watch start be work cup handle entry see break volume least average company post earning growth last quarter sale growth come company earn rank peer medical wholesale drug industry group mckesson mck cardinal health cah be also group highest rate stock related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
128,CAH,mixed finish wednesday marked be many way single handed victory apple aapl lug dow mark nasdaq composite end mostly unchanged iphone maker thunder ahead massive trade pare initial advance only slightly end session buy point flat base result left dow jone industrial average gain remain ever so slightly level seize new high water mark open trade more half dow stock trade lower day walt disney chalk index worst performance nearly deal minor setback house mouse effort scale right side month cup base ahead fiscal third quarter report schedule aug nasdaq composite surrender gain early session undertow tech name lead facebook fb microsoft msft netflix nflx outstripped gain apple illumina ilmn groupon grpn add less come pressure oil related name lead range resource rrc pioneer natural resource pxd newfield exploration nfx drug distribution giant cardinal health cah also have say drop top fiscal fourth quarter expectation guide earning expectation aside apple day big earning winner be illumina spirit aerosystem spr boot barn holding boot illumina soar report late tuesday second quarter earning slip much less expect revenue growth ratchete share take buy point flat base end top buy range boot barn kick gain report late tuesday fiscal first quarter ep soar second quarter acceleration less stock be now july low scramble right side steep month correction spirit report early wednesday second quarter earning jump first gain quarters top analyst view gain launch share past buy point month cup handle base truck maker oshkosh osk pare initial surge gain enough hold just buy point cup handle base report fiscal third quarter earning far analyst target company best outing year session also see winning run break several lead stock most notably macom technology solution mtsi coherent cohr chipmaker macom slice loss compound weak fiscal report target guidance coherent collapse gain earning revenue advance miss expectation stock suffer significant chart damage related nasdaq turn positive early reversal china name strugglemacom earning miss send fiber optic stock china worriesnew iphone fear overblown illumina upgrade stock break biotechs defy downtrend hit fresh high
129,CAH,number high profile medical technology firm include like boston scientific bsx abbott laboratory medtronic mdt be unlikely stand way dutch firm philips bid heart device maker spectranetic spnc analyst say wednesday xon stock market today spectranetic stock rocket record close high philips announce plan acquire spectranetic cash share deal value spectranetic euro needham analyst mike matson say bidding likely stop boston scientific abbott medtronic aren expect bid company spectranetic make drug coat balloon call stellarex treatment disease artery leg stomach arm head narrow rival bard bcr boston scientific medtronic already make drug coat balloon matson write note client further becton dickinson bdx be acquire bard leave major firm sector lack drug coat balloon abbott cardinal health cah terumo suspect abbott be too preoccupy st jude medical alere alr acquisition pursue large deal say similarly cardinal be process acquire medtronic medical supply business ibd take heart valve sector heated last year boston scientific make acquisition bring closer compete medtronic edward lifescience head sector leader look battle be shape matson be unsure terumo acquisition strategy similarly doesn expect philips acquisition get catch regulatory issue philips spectranetic only overlap atherectomy process harden narrow artery be remove body philips get area earlier acquisition believe market share be very low think regulatory issue be unlikely say philips say wednesday expect deal close third quarter dutch firm expect see revenue growth profit accretion matson keep buy rating spectranetic stock boost price target reflect acquisition cost related medtronic edward rivale unit outgrow broader market boston heart valve win face trial rival medtronicedward rocket month high strong heart valve sale
130,CAH,xdrug medical supply distributor cardinal health cah say buy medical supply unit medtronic mdt mostly debt weaker earning guidance cardinal share plunge early tuesday cardinal health be acquire medtronic patient care deep vein thrombosis nutritional insufficiency unit include brand used combine unit generate revenue last report quarters medtronic say include product category multiple market setting include brand such curity kendall argyle kangaroo be used nearly hospital well establish product line be complementary medical consumable business fit naturally customer offer reason product portfolio have be radar many year say cardinal health chairman ceo george barrett ibd take cardinal health share have be rebound presidential election investor believe donald trump be less aggressive drug price hillary clinton statement stock tumble day move average find support cardinal now see fiscal earning share low end earlier guidance expect deal be boost gaap ep continue operation more cent still see ep year be flat mid single digit cardinal health finance acquisition cash new debt standard poor fitch put cardinal credit rating risk downgrade cite increase leverage cardinal health share tumble stock market today gapping day day move average medtronic dip cent cardinal fellow drug distributor mckesson mck sank abc cardinal health paid cordis johnson johnson jnj add portfolio device include catheter filter stent medtronic say transaction reduce ep modestly medtronic spend net proceed deal share buyback rest go cut debt related johnson johnson earning top drug sale be drag
131,CAH,dow jone industrial average lead downside afternoon trading tuesday hurt weakness goldman sachs gs johnson johnson jnj dow fall loss nasdaq composite be volume nyse nasdaq be tracking higher monday level stock market hold relatively well sharp loss london paris overnight paris cac swoon uncertainty outcome france presidential election meanwhile london ftse slump prime minister theresa say ll seek early election june strengthen hand head brexit talk year treasury yield continue bleed fall basis point bond market continue seem odd fed fed current economic outlook stock market today earning report financial sector remain focus goldman sachs gs slump be poise test day move average currently bank america bac reversed lower strong start share be rise early charle schwab schw have lot good news earning report include earning sale beat well highest number new quarterly account year headline didn help stock much share fall cardinal health cah crash company announce plan buy medtronic mdt medical supply unit cardinal also lower full year earning outlook ibd telecom infrastructure firm dycom industry dy clear base buy point share be afternoon trading verizon inked fiber optic cable deal corning glw dycom provide engineering construction maintenance installation service telecom provider intuitive surgical isrg give back ahead earning report close growth have slow dramatically medical device maker best know da vinci robotic surgical system minimally invasive procedure stock continue hold high company sell da vinci system fourth quarter year quarter related uk prime minister call snap election european stock fallgoldman sack wall street giant blame politic trading wo dow verizon buy corning fiber cable tv acquisition hold
132,CAH,unite parcel service up acquire pharmacy license georgia move broaden business not only shipping relabele drug cnbc report xup confirm move say license be tie new potential business engagement handled duluth ga facility not clear strategically significant move be up time company face uncertainty amazon com amzn major customer test own final mile delivery service be negative shipping rate volume amazon also be mull incursion retail prescription drug business also entail role shipping drug challenge drug wholesaler cardinal health cah mckesson mck investor didn initially interpret late day up news threat drug wholesale group share up dip stock market today amazon climb mckesson gain cardinal health amazon footstep already be prompt potential competitor react notably cvs health cvs be discussion buy health insurer aetna aet have announce plan roll next day delivery market same day delivery major market new york city related aetna soar cvs health deal offer top billioncvs same day delivery fight amazon be tough pill swallowopec auto show gm self drive event lead investing action planstock buy watch top ipos big small cap growth stock
133,CAH,cvs health cvs buy aetna aet create health care giant have hand everything insurance corner drugstore cvs pay share aetna share cash rest stock company say statement sunday premium aetna share price oct day company be report be talk deal be biggest health care merger past decade combine largest drugstore chain third biggest health insurer cvs also manage drug benefit plan employer insurer business help steer aetna customer cvs drugstore fill prescription deal give aetna insurance plan closer ground tie customer get care include cvs assumption aetna debt deal be value expect close second half company say joint interview cvs chief executive officer larry merlo aetna ceo mark bertolini say combine company help cvs expand variety retail medical service vision care nutrition advice audiology make basic care more convenient less costly consumer aetna be operated separate business unit new service be design appeal broadly customer other insurance company well executive say immediate financial benefit deal be project be relatively modest company say expect synergy profit improvement low mid single digit second full year merger be complete company be bet longer term profit reshape customer get care create executive be call new front door health care system cvs store clinic think store hub new way access health care service america merlo say joint interview re bring health care person live work cvs drugstore fill prescription cvs drug plan also give aetna insurance plan closer ground tie customer get care deal be finance mix cash debt barclay goldman sachs bank america have commit provide financing person say expect close second half create cost saving say person deal close aetna operate separate unit run member current management aetna chief executive officer mark bertolini join cvs board other aetna director come health sector be look horizon amazon com amzn company shake business buy distribute selling drug medical product get health care retail industry have be batter online giant amazon hasn reveal plan problem health care system be so fragmented so little coordination say steve kraus invest health firm bessemer venture partner better vertically integrate less siloed system be good thing mind also set new round takeover cvs aetna competitor look reshape landscape nov ceo express script esrx say pure play pharmacy benefit manager be open deal right price wasn actively look don need sell be very successful future be always open other sudden conclude want have express script ceo tim wentworth say interview also mentioned possibility partner amazon drug distribution arrangement express script be just company universe independent drug plan insurer supply chain middleman wellcare health plan wcg humana hum centene cnc become merger target cvs aetna deal accord matthew borsch analyst bmo capital market drug distributor cardinal health cah mckesson mck retailer such walgreen boot alliance wba also face pressure find partner cvs operate retail store walk medical clinic have be move drugstore root year buy pharmacy benefit manager caremark rx business make almost half woonsocket rhode island base company operate profit third quarter cvs stop selling cigarette add health name aetna have emphasize desire move care closer consumer brian tanquilut analyst jeffery say oct cvs capability include minute clinic coram home infusion business enable health plan improve health outcome reduce cost trend consolidation be pick health care supplier administrator insurer seek more control consumer get care propose megamerger insurer include deal aetna humana be block year antitrust ground lead company look rival insurer different type health care company potential deal cvs aetna deal antitrust prospect depend regulator be tasked review accord bloomberg intelligence analyst jennifer rie federal trade commission have be less critical consolidation company adjacent business know vertical consolidation justice department other hand last month sue block merger time warner twx vertical deal michael newshel analyst evercore isi say doj effort block time warner deal do raise concern cvs aetna deal do have path forward aetna likely need divest medicare drug plan business say biggest health insurer unitedhealth group unh be also most diversify unite own doctor clinic outpatient surgery chain also have pharmacy benefit management call optumrx build acquisition catamaran corp
134,CAH,cvs health cvs isn take threat amazon com amzn lie xnews drugstore chain be reportedly talk buy health insurer aetna aet more share hit just report amazon have obtain wholesale pharmacy license least dozen state aetna share vault close stock market today cvs share fall recover somewhat aetna news follow amazon report amazon share change little regular trading surge late report quarterly result sail past estimate meanwhile news amazon pharmacy license send walgreen boot alliance wba host drug distributor also get whack abc lose mckesson mck cardinal health cah ibd take thousand publicly trade company choose quickly find best stock buy right now good start point be regularly review screen highlight top rate equity cvs aetna serve member already have close ty aetna signing drugstore giant caremark unit pharmacy benefit management partner spring june tarun mehra co consultancy write cvs buy aetna cvs have impressive suite asset already be add health plan portfolio create truly large scale integrate platform retail pbm mco manage care organization distributor joint venture cardinal health provide cvs strategic advantage unitedhealth group unh optumrx yet just few month potential entry amazon have shake prescription dispense industry analyst be now speculate unitedhealth partner amazon unitedhealth share close add hour related anthem jump prescription business amazon speculation swirlsamazon new online drug retailer cvs walgreen bewarestock buy watch top ipos big small cap growth daily update stock potential big gain
135,CAH,dow industrial nasdaq composite quickly strengthen early gain monday market head holiday shorten week trade dow jone industrial average edge start bell strong early loss merck mrk nike nke feel early drag alcoa aa cardinal health cah nasdaq apple aapl fang stock open red quickly reversed positive trade china netease nte shed stock bond market be close thursday run shorten session friday stock trading end et ibm ibm muscle early lead dow ahead verizon vz gain verizon receive upgrade outperform market perform well fargo note also lift verizon price target verizon share end friday october high cavium cavm blast higher chip developer accept takeover bid bermuda base marvell technology group mrvl advantageous tax reason deal be expect close mid marvell share leap open cavium ibd stock be extend breaking buy point cup handle base marvell be buy range buy point also cup handle base urban outfitter urbn dip fraction early trade ahead third quarter report due close owner urban outfitter anthropologie chain last week surge strong trade lift stock june low leave just midpoint deep month consolidation china alibaba group holding baba rise news report commerce giant be take stake china base big box retailer sun art retail group alibaba ibd leaderboard ibd list end friday test support day move average clear buy point mid september ibd stock national beverage fizz pop fort lauderdale fla base drink maker receive upgrade positive neutral price target hike susquehanna stock be week move average have be find support week line tenth week possible base pattern rival soft drink maker monster beverage mnst fall more price target hike credit suisse maintain outperform rating ibd stock share be extend flat base buy point simple session economic news only lead economic indicator october due conference board et asian market japan tokyo nikkei drop clipping day rebound china market post modest gain hong kong hang seng index advance europe market be positive dax frankfurt rebound gain cac paris dax re-cover sharp early loss follow break attempt build coalition government result left chancellor angela merkel flounder control europe largest economy majority hand caretaker government related future fall merkel coalition talk fail marvell cavium big picture market surprising week feature earning tech giant strengthen retail stock black friday near
136,CAH,even cvs health cvs walgreen boot alliance wba have repeatedly throw cold water idea amazon com amzn take prescription dispense industry idea just win die xon thursday bernstein analyst lance wilke seem ante amazon rumore interest sector say expect happen accord thefly com wilke see amazon buy partner pharmacy benefit management company help drive volume navigate industry regulation wilke have be work cover health care service arena quarter century so perspective amazon be well position disrupt industry carry weight investor note concern amazon entry negative effect pbm industry earning report amazon be likely longer run concern investor so pharmacy focus thursday be weak sale rite aid rad cite challenge reimbursement rate environment new generic hold prescription price report earning amazon share add head back day move average rite aid share tumble hit year low stock market today cvs be drugstore pbm slip walgreen lose walgreen month win ftc approval buy rite aid store long battle buy smaller rival fall apart due regulatory objection dow component unitedhealth group unh operate optumrx pharmacy benefit management company rise lag solid gain see other manage care player express script esrx largest pure play pbm be higher health care group suffering most thursday be drug distributor mckesson mck fall abc cardinal health cah amazon be enter pharmaceutical industry industry watcher have speculate cut distributor deal directly drug manufacturer ibd take ibd premium feature be free oct visit ibd stock checkup see stock portfolio watch list match industry peer base earning sale margin stock performance also read big picture daily update underlie market trend aug ibd shift market trend gauge confirm uptrend uptrend pressure equivalent flash yellow light turn green earning call aug cvs ceo larry merlo discuss host reason industry not play amazon strong suit addition be distribution point pharmacy be also clinical outcome be provide merlo say accord seek alpha transcript environment migration more value base care clinical capability be go continue grow importance merlo say highly regulate industry have high barrier entry note work require pharmacist payer physician add patient put trust retail pharmacist add mail order pharmacy have decline recent year have speculate amazon use whole food location place store pharmacy pickup related market be amazon next casualty notrite aid stock crash same store declinestock buy watch top ipos big small cap growth stock
137,CAH,catalent ctlt company have amassed big business very small dose break month base powerful gap tuesday somerset company make capsule other delivery technology used patient consumer ingest drug fiscal year end june catalent count top
138,CAH,many customer brace change obamacare drug wholesaler be expansion mode head overseas form purchasing co op see fit massive piece healthcare puzzle be home huge competitor mckesson mck largest abc be expand heavily europe mainly
139,CAH,flu season get weak start largest drugstore chain rally anyway earning season get underway week
140,CAH,wag largest retail drug chain report result fiscal first quarter friday day rite aid rad weigh
141,CAH,analyst expect earning shoot last year cent share settle contract dispute vs express script esrx last year earning have grow double digit february end quarter easy comparison prior year help
142,CAH,also presumably save money global generic drug sourcing venture swiss base alliance boot drug distributor abc joined march
143,CAH,rite aid have be turnaround mode buy most brand drug generic distributor mckesson mck be process acquire german drug wholesaler celesio also move meant keep cost
144,CAH,last week drug wholesaler cardinal health cah announce be form generic drug buy venture cvs caremark cvs drugstore chain pharmacy benefit manager
145,CAH,cost saving be work pharmacy side account more drugstore overall revenue retail environment front store have be tough chain have be try drive traffic sale heavy promotion analyst say
146,CAH,sale have grow slower pace earning even stake take alliance boot august
147,CAH,chain pre report revenue be same store increase largely due gain pharmacy side
148,CAH,prescription filled store open least month increase pharmacy sale grow slow start flu season negatively impact pharmacy sale percentage point number flu shot have administer date be vs last year
149,CAH,front end comparable sale grow only november sale be consensus heavy discounting environment
150,CAH,promotional tone sale report write credit suisse analyst edward kelly research note seem telegraph more difficult gross margin
151,CAH,rite aid say earlier total sale rise same store sale be front end same store sale fall pharmacy same store sale rise
152,CAH,rite aid post first profit year february end fiscal year have see gain then profit be see dip cent
153,CAH,term be somewhat more bumpy rite aid recent quarters write jpmorgan analyst lisa gill cite economy reimbursement pressure ongoing work execute turnaround plan
154,CAH,early november cvs report gain earning september end share be third straight quarter double digit profit growth revenue grow nearly flu season get weak start largest drugstore chain rally anyway earning season get underway week wag largest retail drug chain report result fiscal first quarter friday day rite aid rad weigh analyst expect earning shoot last year cent share settle contract dispute vs express script esrx last year earning have grow double digit february end quarter easy comparison prior year help also presumably save money global generic drug sourcing venture swiss base alliance boot drug distributor abc joined march rite aid have be turnaround mode buy most brand drug generic distributor mckesson mck be process acquire german drug wholesaler celesio also move meant keep cost last week drug wholesaler cardinal health cah announce be form generic drug buy venture cvs caremark cvs drugstore chain pharmacy benefit manager cost saving be work pharmacy side account more drugstore overall revenue retail environment front store have be tough chain have be try drive traffic sale heavy promotion analyst say sale have grow slower pace earning even stake take alliance boot august chain pre report revenue be same store increase largely due gain pharmacy side prescription filled store open least month increase pharmacy sale grow slow start flu season negatively impact pharmacy sale percentage point number flu shot have administer date be vs last year front end comparable sale grow only november sale be consensus heavy discounting environment promotional tone sale report write credit suisse analyst edward kelly research note seem telegraph more difficult gross margin rite aid say earlier total sale rise same store sale be front end same store sale fall pharmacy same store sale rise rite aid post first profit year february end fiscal year have see gain then profit be see dip cent term be somewhat more bumpy rite aid recent quarters write jpmorgan analyst lisa gill cite economy reimbursement pressure ongoing work execute turnaround plan early november cvs report gain earning september end share be third straight quarter double digit profit growth revenue grow nearly
155,CAH,cardinal health cah extend gain tuesday announcement deal cvs caremark cvs form largest generic drug sourcing business
156,CAH,spark bullish comment upgrade research firm include leerink swann lift drug distributor outperform market perform set price target say expect joint venture drive growth
157,CAH,baird raise price target
158,CAH,cardinal health share be early afternoon trading stock market today cvs edge
159,CAH,cardinal cvs enter year joint venture buy generic drug combine purchasing power be expect help secure better price negotiation generic drugmaker
160,CAH,agreement cardinal health pay quarter cvs duration contract tax total
161,CAH,deal become active july follow similar move rival increase number generic drug hit market
162,CAH,wag drug wholesaler abc strike year supply deal march drug distributor mckesson mck be reportedly make bid acquire german counterpart celesio
163,CAH,follow nancy gondo twitter ibd_ngondo cardinal health cah extend gain tuesday announcement deal cvs caremark cvs form largest generic drug sourcing business spark bullish comment upgrade research firm include leerink swann lift drug distributor outperform market perform set price target say expect joint venture drive growth baird raise price target cardinal health share be early afternoon trading stock market today cvs edge cardinal cvs enter year joint venture buy generic drug combine purchasing power be expect help secure better price negotiation generic drugmaker agreement cardinal health pay quarter cvs duration contract tax total deal become active july follow similar move rival increase number generic drug hit market wag drug wholesaler abc strike year supply deal march drug distributor mckesson mck be reportedly make bid acquire german counterpart celesio follow nancy gondo twitter ibd_ngondo
164,CAH,wag report first quarter sale friday just miss earning only meet view fewer new generic drug continue soft economy share rise drugstore giant see better time ahead fiscal earning rise cent share expect include defer tax benefit cent partnership
165,CAH,ambitious go getter often face quandary plot career path do climb straight corporate ladder do lateral move broaden experience john hartmann president chief executive true value co chicago have wrestle question didn always arrive best answer hartmann take top
166,CAH,mckesson mck report talk acquire german drug distributor celesio follow wag success alliance boot abc deal pricing financing arrangement be still be negotiate biggest drug distributor celesio top shareholder franz haniel cie accord wall street journal such deal give
167,CAH,first quarter earning season have take center stage member elite index have report financial number so far latest earning preview performance index participant indicate increase total earning higher revenue beat ratio have be impressive well company surpass bottom line expectation beating top line mark medical sector zack sector have put stellar show so far sector be expect rise revenue growth earning season await medical product stock medical product industry have be gain prominence late courtesy increase life expectancy rate age population change market dynamic use technologically superior device fact industry be not dependent just medical advancement solely nowadays rely technological advancement microelectronic instrumentation biotechnology software development industry well view trend investor sentiment have be solid medical product company fact industry have return compare rally year time further bipartisan suspension medical device tax have give significant boost sector first quarter meanwhile medtech bigwig baxter international bax free report ecolab ecl free report have report upbeat first quarter number company have beaten consensus estimate count strong outlook now let take look company be set release result becton dickinson company bdx free report second quarter fiscal result be likely show strong outcome core bd medical segment management steady growth sub segment medication procedural solution pharmaceutical system be expect be growth propeller however improvement other segment lead improve result read more bd medical drive becton dickinson earning zack consensus estimate second quarter earning be peg reflect year year growth bd have earning esp zack rank hold zack quantitative model stock advantageous combination solid zack rank strong buy buy positive earning esp have higher chance beating estimate uncover best stock buy sell re report earning esp filterbecton dickinson company price ep surprise becton dickinson company price ep surprise becton dickinson company quotecardinal health inc cah free report third quarter fiscal result be likely reflect decline core pharmaceutical segment growth other segment be likely make decline partially however raise guidance buoy optimism furthermore medical segment be expect post solid number medical glove unit result witness softness quarter be report read more store cardinal health earning zack consensus estimate third quarter earning be peg reflect decline year year company have earning esp zack rank see complete list today zack rank stock here cardinal health inc price ep surprise cardinal health inc price ep surprise cardinal health inc quoteteleflex incorporate tfx free report first quarter earning be expect be strong back vascular unit north america emea sale be also likely be high zack consensus estimate earning be pin indicate year year growth teleflex have earning esp zack rank teleflex incorporate price ep surprise teleflex incorporate price ep surprise teleflex incorporate quoteabiom inc abmd free report be likely see strong fourth quarter fiscal back flagship product line impella notably last report quarter impella revenue rise internationally impella revenue increase whopping plethora regulatory approval impella impella cp be encourage moreover increase guidance buoy optimism zack consensus estimate earning be cent reflect year year growth company have earning esp zack rank abiom inc price ep surprise abiom inc price ep surprise abiom inc quotelook stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
168,CAH,dentsply sirona inc xray free report first quarter result be schedule release market open company cad cam imaging platform be expect boost result quarter be report improvement other unit be tailwind well last report quarter dentsply post adjust earning share ep cent beating zack consensus estimate penny however metric decline year year net sale increase year quarter also figure surpass zack consensus estimate rise constant currency cc exchange rate currently zack consensus estimate earning quarter be report be peg cent share reflect decline year year zack consensus estimate net sale be project show improvement year year let delve major factor influence dentsply performance quarter be report expect dentsply company cad cam unit be likely drive top line first quarter cad cam be dental imaging platform major foundation global dental market last report quarter dentsply announce consistent focus sale force effectiveness be likely boost result present be sale force close person employ globally sale sale support quarter be report prospect innovation be other growth driver recently company announce plan redirect industry lead budget high impact project provide better competitive position dentsply sirona inc price ep surprise dentsply sirona inc price ep surprise dentsply sirona inc quotedentsply confirm have undertake measure reduce interest expense approximately end be likely boost first quarter result overall company have very low cost debt structure ample availability grow business make acquisition mar dentsply announce definitive agreement acquire orametrix lead industry provider innovative technology solution company also offer advanced cad platform develop dental professional deliver consistently predictable orthodontic outcome transaction be expect be complete second quarter dentsply overall growth strategy rest product innovation company solid internal growth challenge macroeconomic headwind be primarily drive innovative new product do model predict solid prospect quantitative model do not show beat dentsply earning season be stock need have positive earning zack rank strong buy buy hold be able beat estimate zack esp earning esp dentsply be uncover best stock buy sell re report earning esp filter zack rank dentsply carry zack rank strong sell notably caution stock zack rank sell go earning announcement especially company be see negative estimate revision stock worth lookhere be few medical stock worth consider have right combination element post beat earning season becton dickinson company bdx free report have earning esp zack rank see complete list today zack rank stock here cardinal health inc cah free report have earning esp zack rank cooper company inc coo free report have earning esp zack rank look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
169,CAH,cardinal health inc cah free report third quarter fiscal result be schedule release market open result be likely show decline core pharmaceutical segment growth other segment be likely make partially second quarter fiscal company report adjust earning share prior year quarter also zack consensus estimate revenue come year year basis outpace consensus estimate notably cardinal health have negative average earning surprise trail quarters zack consensus estimate third quarter earning be peg reflect decline year year same revenue be pin indicate growth cardinal health inc price ep surprise cardinal health inc price ep surprise cardinal health inc quotelet delve deeper pharmaceutical segment focusin last report quarter segment account enormous company revenue revenue segment come year year basis segment witness strong growth specialty business also gain huge number pharmaceutical distribution customer however see drop profit thank generic pharmaceutical pricing recent investment pharmaceutical platform lackluster generic program performance management growth segment be further impede expiration large mail order prime therapeutic current quarter zack consensus estimate revenue sequentially other factor playguidance liftedconsider benefit slash federal tax rate cardinal health raise fiscal outlook company expect adjust earning share continue operation compare previous range medical segmentin fiscal second quarter segment account company revenue revenue segment grow primarily drive patient recovery acquisition medical segment profit increase courtesy higher contribution new exist customer acquisition patient recovery business current quarter zack consensus estimate revenue segment be peg sequentially medical glove unitcardinal health offer robust portfolio medical glove include surgical glove exam glove clean room glove company have be lately face challenge exam glove sub segment last report quarter commodity pricing supply disruption be major draghunt section fiscal lower expectation medical segment due trouble exam glove segment raise concern quantitative model do not conclusively predict earning beat cardinal health earning season be stock need have positive earning esp zack rank strong buy buy hold be able beat estimate zack esp earning esp cardinal health be uncover best stock buy sell re report earning esp filter zack rank cardinal health carry zack rank sell stock worth lookhere be few medical stock worth consider have right combination element post beat earning season stryker corporation syk free report have earning esp zack rank see complete list today zack rank stock here hologic inc holx free report have earning esp zack rank edward lifescience ew free report have earning esp zack rank make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
170,CAH,varian medical system inc var free report be schedule report second quarter fiscal earning apr market close favorable revenue opportunity various oncology imaging component product grow adoption proton therapy strong overseas presence be likely drive company second quarter fiscal earning last quarter company deliver adjust earning share beat zack consensus estimate cent adjust earning also improve year year basis revenue totale beat zack consensus estimate second quarter zack consensus estimate revenue be peg reflect rise year year zack consensus estimate adjust earning be peg share indicate increase year year varian medical system inc price ep surprise varian medical system inc price ep surprise varian medical system inc quote let delve factor be likely impact varian medical upcoming quarterly result factor playoncology drive growth be upbeat varian medical oncology business account company total revenue last quarter notably company have be address tier mid tier market edge truebeam vitalbeam product have be winning international contract oncology space bid overhaul oncology system segment varian medical recently acquire montreal base privately hold evinance innovation inc clinical decision support cds software company deal be initiate september company have state utilize evinance patented technology offer better service client mar varian medical announce st petersburg center nuclear medicine successfully complete first pediatric patient treatment varian probeam proton therapy system product launch successful launch halcyon therapy system deserve mention regard varian medical have be undertaking initiative attract customer broad spectrum product recently company unveil halcyon radiotherapy treatment system recently first quarter fiscal halcyon platform witness order inception reflect solid demand platform quarters ahead jan varian medical announce halcyon system have receive taiwan fda approval allow company market new cancer treatment system country feb varian medical announce halcyon cancer treatment platform receive atomic energy regulatory board aerb certificate import supply india company expect revenue range adjust earning share be expect band cash flow operation be project range cut throat competition varian medical compete large electronic company such siemens philips well smaller more specialize radiation therapy equipment manufacturer elekta accuray emerge proton therapy market company face competition hitachi ion beam application mevion medical system sumitomo intense competition be anticipate increase expenditure nascent proton therapy market dent margin moreover pricing pressure traditional radiotherapy be major concern earning whispersour proven model do not show earning beat varian medical quarter be stock need have positive earning zack rank strong buy buy hold happen be not case here see zack esp varian medical currently have earning esp uncover best stock buy sell re report earning esp filter zack rank varian medical carry zack rank increase predictive power esp however company esp make surprise prediction difficult please note caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision stock worth lookhere be few medical stock worth consider have right combination element post earning beat quarter bio rad laboratory bio free report have earning esp zack rank see complete list today zack rank stock here cardinal heath cah free report have earning esp zack rank abbott laboratory free report have earning esp zack rank breaking news cryptocurrency now bigger total market cap cryptos recently surpass more increase previous month re now bigger morgan stanley goldman sachs even visa new asset class expand even more rapidly new investor continue pour wall street become increasingly involved zack have just name company enable investor take advantage explosive growth cryptocurrency stock market click here access stock
171,CAH,baxter international inc bax free report be schedule report first quarter earning apr market open positive tiding regulatory front expand product portfolio strategic collaboration strong presence international market be key positive moment expect company witness steady growth hospital product sale major revenue component be project drive first quarter earning expect improvement revenue other sub segment generate impressive result last quarter baxter post adjust earning share cent beat zack consensus estimate cent improve year quarter figure cent current quarter zack consensus estimate revenue be peg reflect rise year year zack consensus estimate adjust earning share be peg cent indicate increase year year baxter international inc price ep surprise baxter international inc price ep surprise baxter international inc quotelet delve other factor be likely impact baxter first quarter result hospital product drive resultsbaxter have impressive product portfolio improve exist product new product development recently company announce distribution agreement launch arisure close system transfer device last quarter hospital sale be drive solid demand injectable pharmaceutical hospital pharmacy compound service sale segment benefit solid demand company advanced surgery product cytotoxic contract manufacturing service overall zack consensus estimate hospital product revenue be peg reflect increase year quarter here take sneak peek major sub segment hospital product be poise gain be report quarter surgical care surgical care include anesthesia biosurgery sale record year year sale growth last quarter low double digit growth anesthesia critical care product drive grow demand inhaled anesthetic internationally well increase sale brevibloc fast act iv beta blocker mar baxter complete acquisition hemostat sealant product mallinckrodt plc expand exist surgical portfolio hemostat sealant especially intraoperative bleed notably company buy thrombin topical preveleak surgical sealant product line mallinckrodt baxter surgical portfolio include product floseal hemostatic matrix tisseel fibrin sealant coseal surgical sealant vascu guard patch other portfolio be compose hemostasis address bleed tissue sealing hard tissue regeneration well soft tissue repair microsurgery product available nearly country company consistently strive improve advanced surgery business company expect advanced surgery business increase constant currency cc basis baxter announce plan focus launch advanced surgery product japan come day zack consensus estimate segment sale be peg reflect rise year quarter fluid system hospital product sale fluid system be expect be solid robust iv solution sale unite state expect fluid system maintain trend first quarter be evident zack consensus estimate fluid system first quarter reflect rise year quarter integrate pharmacy solution ip global sale ip sub segment hospital product increase formidable margin last quarter partly back increase sale premixed injectable drug however baxter performance last year have lack luster majorly lower sale threat integrate pharmacy solution franchise business baxter expect sale be approximately reflect decline upcoming quarterly result lower sale be expect impact top line low single digit first quarter zack consensus estimate ip be peg show increase year number other factor playguidance baxter expect first quarter adjust earning range cent however net sale first quarter be expect be affected approximately due disruption puerto rico facility baxter estimate sale growth approximately cc adjust earning be expect band regulatory approval baxter have be witness positive tiding regulatory front recently baxter announce approval bivalirudin percent sodium chloride injection bivalirudin management confirm fda have grant new approval temporary importation certain drug facility canada mexico development baxter now have operational site approve address demand market dull projection pharmaceutical unit pharmaceutical business include baxter broad generic injectable portfolio anesthesia critical care product well hospital pharmacy compound service conduct outside unite state be expect be flat year year basis lackluster performance be primarily drive increase competition select product segment further other business segment primarily include baxter contract manufacturing service management expect low single digit decline management sale segment benefit customer order baxter expect lower manufacturing revenue shire acquire year model predictsour quantitative model do not predict earning beat baxter quarter be stock need have positive earning zack rank strong buy buy hold be able beat estimate zack esp earning esp baxter be uncover best stock buy sell re report earning esp filter zack rank baxter carry zack rank stock worth lookhere be few medical stock worth consider have right combination element post earning beat quarter bio rad laboratory bio free report have earning esp zack rank see complete list today zack rank stock here cardinal heath cah free report have earning esp zack rank abbott laboratory free report have earning esp zack rank breaking news cryptocurrency now bigger total market cap cryptos recently surpass more increase previous month re now bigger morgan stanley goldman sachs even visa new asset class expand even more rapidly new investor continue pour wall street become increasingly involved zack have just name company enable investor take advantage explosive growth cryptocurrency stock market click here access stock
172,CAH,stryker corporation syk free report first quarter result be schedule release apr market close company acquisition drive strategy be expect boost growth expand exist product offering business segment expect company witness steady growth orthopaedic implant sale major revenue component be project drive first quarter earning expect improvement revenue other segment especially medsurg help company generate impressive result notably last quarter stryker post earning share beat zack consensus estimate penny current quarter zack consensus estimate revenue be peg reflect rise year year zack consensus estimate earning be peg indicate increase year year let delve other factor be likely impact skryker first quarter result orthopaedic implant focus mako implant contribute net revenue last quarter zack consensus estimate orthopaedic implant stand reflect rise year year recently stryker introduce robotic arm assist total knee arthroplasty application use mako system notably be first only robotic technology be used total knee hip partial knee replacement procedure notably mako total knee utilize stryker robotic platform triathlon total knee system guide ct base modele bone anatomy stryker system enable intra operative plan assist bone resection procedure fourth quarter mako total knee platform drive stryker earning mako robot installation totale globally unite state additionally company have first robot sale japan approval mako be expect end company exit mako robot install unite state stryker corporation price consensus stryker corporation price consensus stryker corporation quoteother factor playmedsurg unit drive growthmedsurg equipment product include surgical equipment surgical navigation system endoscopic communication digital imaging system well patient handle emergency medical equipment last quarter management announce medsurg high growth segment zack consensus estimate medsurg endoscopy revenue surge year year acquisition drive strategystryker have be follow acquisition drive strategy drive growth recently stryker acquire entellus medical inc cash transaction share equity value approximately enable physician conveniently perform broad range ent procedure late stryker acquire vexim specialize development sale vertebral compression fracture solution vexim flagship product be spinejack system mechanical expandable vcf implant fracture reduction stabilization vexim portfolio be highly complementary interventional spine business stryker stryker instrument division include extensive innovative portfolio vertebral augmentation vertebroplasty radiofrequency ablation procedure diagnostic tool decompression treatment advance contain disc herniation lower demand healthcare productsstryker persistently face challenge lower demand health care product additionally company spine business unite state be plague supply issue fourth quarter fact stryker expect face headwind be report quarter company have be face challenge economic condition particularly unite state western europe additionally lower reimbursement medical product service impose downward pressure price company product longer sale cycle slower adoption new technology ultimately impact top line model predictsour quantitative model predict earning beat stryker quarter be stock need have positive earning esp zack rank strong buy buy hold be able beat estimate be illustrated zack esp earning esp stryker be uncover best stock buy sell re report earning esp filter zack rank stryker carry zack rank favorable zack rank increase predictive power esp company positive esp make surprise prediction feasible other stock worth lookhere be few other medical stock worth consider also have right combination element post earning beat quarter bio rad laboratory bio free report have earning esp zack rank see complete list today zack rank stock here cardinal heath cah free report have earning esp zack rank abbott laboratory free report have earning esp zack rank investor alert breakthrough pendinga medical advance be now flashpoint theory realization billion dollar research have pour company be already generate substantial revenue even more wondrous product be pipeline cure variety deadly disease be sight so be big potential profit early investor zack name stock buy now click here see
173,CAH,value investing be easily most popular way find great stock market environment wouldn want find stock be fly radar be compelling buy offer tantalize discount compare fair value way find company be look several key metric financial ratio many be crucial value stock selection process let put cardinal health inc cah free report stock equation find be good choice value oriented investor right now investor subscribe methodology look elsewhere top pick pe ratioa key metric value investor always look be price earning ratio pe short show much investor be willing pay dollar earning give stock be easily most popular financial ratio world best use pe ratio be compare stock current pe ratio ratio have be past compare average industry sector compare market whole front cardinal health have trail month pe ratio see chart level actually compare pretty favorably market large pe stand focus long term pe trend cardinal health current pe level put midpoint past year fact current level stand closer lows stock suggest great scope entry further stock pe also compare favorably zack medical sector trail month pe ratio stand very least indicate stock be relatively undervalue right now compare peer also point cardinal health forward pe be roughly same trail month value so say forward earning estimate be incorporate company share price now define forward pe current price relative zack consensus estimate current fiscal year ratioanother key metric note be price sale ratio approach compare give stock price total sale lower read be generally consider better person metric more other value focuse one look sale something be far harder manipulate accounting trick earning right now cardinal health have ratio be bit lower average come right now broad value outlookin aggregate cardinal health currently have value score putt top stock cover look make cardinal health solid choice value investor other key metric make pretty clear too example cf ratio great indicator value ratio cardinal health be just level be far lower industry average clearly cah be solid choice value front multiple angle stock overall cardinal health be good choice value investor be plenty other factor consider investing name particular be worth note company have growth score momentum score give cah zack vgm score overarch fundamental grade read more zack style score here meanwhile company recent earning estimate have be quite discourage current quarter have see estimate go past day compare upward revision full year estimate have see downward upward revision same time period have have negative impact consensus estimate current quarter consensus estimate have decline past month full year estimate have drop see consensus estimate trend recent price action stock chart cardinal health inc price health inc price consensus cardinal health inc quotegiven bearish trend stock have just zack rank hold be be look line performance company term bottom linecardinal health be inspire choice value investor be hard beat incredible lineup statistic front have zack rank stock belong industry be rank top more zack industry indicate broader factor be favorable company so value investor want estimate turn name first once happen stock be compelling pick make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
174,CAH,feb issue update research report thermo fisher scientific inc tmo free report lead scientific instrument maker stock have zack rank hold thermo fisher end fourth quarter promising note adjust earning revenue beating zack consensus estimate be encourage company solid international performance strong year year growth asia pacific emerge market china south korea middle east also series product launch major progress precision medicine initiative have benefit company performance thermo fisher acquisition fei company have already start boost analytical instrument portfolio thermo fisher scientific inc price thermo fisher scientific inc price thermo fisher scientific inc quote also company deploy strategic acquisition add lead biopharma contract development manufacturing service patheon significantly enhance company value proposition biopharma customer patheon have start contribute company laboratory product service segment additional good news be thermo fisher have strong cash balance enable provide solid return investor past month thermo fisher have successfully trade broader industry stock have rally surpass broader industry gain period promising guidance be more encourage indicate overall bullish trend continue year ahead last quarter company business segment be impact strategic investment unfavorable business mix also competitive headwind rise operate cost persistently threat apart thermo fisher derive majority revenue international market expose foreign currency fluctuation key pickssome better rank stock broader medical space be abiom abmd free report athenahealth athn free report cardinal health cah free report sporting zack rank strong buy see complete list today zack rank stock here abiom have expect long term growth rate stock have soar last month ahead broader industry performance athenahealth have project long term growth rate stock have climb last month industry gain cardinal health have expect long term growth rate last month stock have gain higher industry rise today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
175,CAH,thursday nasdaq composite close record high level lead strong performance medium telecom stock court approval time warner merger deal fuel medium telecom stock rally moreover strong economic datum decision european central bank ecb persist low interest rate mid bolster investor confidence however dow decline marginally drop year treasury yield follow ecb decision affected major banking stock dow jone industrial average dji close however index inx increase close nasdaq composite index ixic close gain total share be trade thursday higher last session average share advancer outnumber decliner nyse ratio nasdaq advancer have edge decliner ratio cboe vix decrease close biggest day percentage decline jun do benchmark perform dow lose reflect third straight loss share jpmorgan chase co jpm free report lose emerge largest drag blue chip index jpmorgan chase carry zack rank hold see complete list today zack rank strong buy stock here notably stock blue chip index close red trade green remain unchanged be due gain utility select sector spdr xlu increase real estate select sector spdr xlre consumer discretionary select sector spdr xly partially offset loss financial select sector spdr xlf notably sector benchmark index end positive territory tech laden nasdaq composite increase close record high level index reach time high level intraday trading strong performance medium telecom stock be primary driver tech heavy index medium telecom stock rally district court verdict favor unconditional merger inc time warner inc immediately trigger battle comcast corp cmcsa free report walt disney co free report regard acquisition majority asset first century fox inc foxa free report speculation many more merger deal future integrate telecom cable tv medium space have significantly raise stock price most major stock medium telecom cable tv industry tech base nasdaq composite be largest beneficiary market trend help index achieve new time high level ecb follow low interest policyon jun ecb announce govern council meeting central bank continue low interest rate policy benchmark rate remain unchanged mid moreover central bank have opted phased elimination ongoing monthly bond purchase program end year ecb expect continue purchasing month worth bond end september follow period mid term inflation datum come line expectation then central bank reduce bond purchase month end december ultimately end program ecb decision reduce yield year treasury note basis point affect major banking stock economic datum commerce depart report retail sale soar biggest rise november consensus estimate be increase meanwhile retail sale datum april be revise instead previously report gain auto sale rise compare gain april sale build material store rebound decline april sale clothing store rise largest gain march sale restaurant bar climb biggest gain january labor department report application unemployment benefit drop seasonally adjust week end jun lower consensus estimate initial claim decline year low reflect grow tightness labor market unemployment rate low stock make headlinemichael company top earning fall soft viewshare michael company inc mik free report decline much yesterday reason stock slump be soft comparable store sale read more cardinal health cd jointly invest health inc cah free report clayton dubilier rice cd recently announce joint investment plan navihealth read more wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
176,CAH,cardinal health cah free report premarket approval pma application incraft incraft stent graft system recently receive favorable recommendation fda circulatory system device panel medical device advisory committee vote favor system notably incraft system come cardinal health cordis unit be acquire earlier however end third quarter fiscal cordis unit performance lack luster significantly affected cardinal health earning effective tax rate hence pma incraft system have be timely help cardinal health secure broader customer base cordis unit incraft system incraft system be cardiovascular platform have advanced endovascular aneurysm repair evar technology treatment infrarenal abdominal aortic aneurysm aaas severe complex condition article experimental clinical cardiology aaa rupture cause death year unite state additional death result repair procedure perform prevent rupture market prospectsper research market global market cardiovascular device reach nearly scale cagr period report further state medical need patient time high increase incidence lead significant growth cardiovascular market price performancewe believe positive development boost share cardinal health have decline year time compare unfavorably industry gain other major health medical pharmaceutical offering lend company competitive edge niche space company offer industry expertise expand portfolio safe product example cardinal health bathroom safety mobility exam room equipment product be exclusively design patient care giver variety product range wheelchair crutch exam room table commode cardinal health offer right mix medical equipment cardinal health ecg monitoring electrode offer quality performance be free neoprene lead mercury be not make natural rubber latex be highly exclusive market cardinal health offer full line baby product well include baby shampoo body wash baby lotion baby powder baby oil more zack rank key pickscardinal health currently carry zack rank strong sell few better rank stock broader medical space be abiom inc abmd free report genomic health inc ghdx free report stryker corporation syk free report abiom have long term growth rate stock sport zack rank strong buy see complete list today zack rank stock here genomic health have expect growth rate zack rank stryker have project long term earning growth rate stock carry zack rank hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
177,CAH,dec issue update research report cardinal health inc cah free report stock carry zack rank hold cardinal health follow acquisition drive strategy focus investing key business gain traction boost profit line company recently enter agreement buy radioactive diagnostic drug lymphoseek navidea be also encourage note cardinal health be pursue growth joint venture long term supply agreement company enter long term agreement henry schein latter purchase cardinal health medical supply physician practice collaboration be expect drive cardinal health earning long haul meanwhile cardinal health pharmaceutical segment have be gain solid client retention loss only few key customer walgreen boot alliance inc wba free report express script hold company esrx free report recently cordis cardinal health company medinol announce receipt fda approval elunir drug eluting stent de treat narrowing blockage coronary artery cardinal health also recently launch opioid action program cardinal health share price movement last year have fail impress stock have lose almost compare unfavorably broader industry gain cardinal health face risk lose considerable business case loss major customer turn severely impair revenue also cardinal health face tough competition business segment instance pharmaceutical supply chain business face competition like mckesson abc free report well several smaller medical surgical distributor such henry schein owen minor see complete list today zack rank strong buy stock here more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
178,CAH,cardinal health inc cah free report recently agree sell cardinal health china business shanghai pharmaceutical hold co ltd sale include cardinal health pharmaceutical medical product distribution business china company asset disposal help streamline chinese operation liability employee infrastructure various system process be transfer shanghai pharma close transaction share price health price movement past month have be unfavorable company share have lose almost compare industry gain current level be also lower rally come back news divestiture do not include cardinal health remain business china include cordis company recently acquire patient recovery business medical sourcing team cardinal health headquarter dublin be national drug distributor provider service pharmacy healthcare provider manufacturer recently cardinal health report solid first quarter fiscal end sep number courtesy stable performance medical segment encourage fiscal guidance also instill confidence stock meanwhile company be banking strategic buyout joint venture supply agreement drive growth pharmaceutical segment witness strong growth specialty business gain huge number pharmaceutical distribution customer profit segment be hurt generic pharmaceutical pricing increase generic pricing pressure be major headwind intense competition customer concentration be other bottleneck sluggish macroeconomic scenario tough product pricing environment be likely impede growth zack rank key pickscardinal health carry zack rank hold few better rank stock health care sector be sucampo pharmaceutical inc therapeutic incorporate cort free report achillion pharmaceutical inc achn free report sucampo sport zack rank strong buy achillion carry zack rank buy see complete list today zack rank stock here sucampo earning share estimate have increase last day company deliver positive earning surprise trail quarters average beat earning share estimate have moved cent cent cent cent last day company deliver positive earning surprise trail quarters average beat company share have rally year date achillion loss estimate share have narrow cent cent cent cent last day company deliver positive earning surprise trail quarters average beat hottest tech mega trend last year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
179,CAH,cardinal health inc cah free report report first quarter fiscal adjust earning share beat zack consensus estimate however earning decline year year basis revenue increase year year basis almost miss zack consensus estimate stock have zack rank sell segmental segment pharmaceutical revenue inched year year basis segment witness strong growth specialty business also gain huge number pharmaceutical distribution customer segment witness drop profit thank generic pharmaceutical pricing company recent investment pharmaceutical platform however solid performance red oak sourcing platform have partially offset negative effect medical segment revenue segment increase primarily higher contribution new exist customer medical segment profit increase courtesy higher contribution new exist customer acquisition however lower contribution veteran affair contract partially affected sale segment cardinal health inc price consensus cardinal health inc price consensus cardinal health inc quote major highlightsin report quarter cardinal health close acquisition medtronic mdt free report patient recovery business cash further cardinal health launch connectsource new cloud base patient engagement platform first quarter cardinal health enter agreement first quarter distribute self manufacture surgeon glove directly certain international market company also announce agreement make cordis subsidiary exclusive distributor medinol coronary stent unite state marginsas percentage revenue gross margin expand basis point bps net revenue distribution selling general administrative sg expense increase year year basis report quarter company reaffirm fiscal guidance adjust earning share continue operation takecardinal health end first quarter fiscal solid note courtesy solid performance medical segment encourage fiscal guidance instill confidence stock meanwhile company be banking strategic buyout joint venture supply agreement drive growth deal medtech bigwig medtronic be likely boost company growth trajectory flipside pharmaceutical segment witness strong growth specialty business gain huge number pharmaceutical distribution customer profit segment be hurt generic pharmaceutical pricing increase generic pricing pressure be major headwind intensify competition customer concentration be other bottleneck sluggish macroeconomic scenario tough product pricing environment be likely impede growth peer surgical inc isrg free report post adjust earning share third quarter beating zack consensus estimate stellar revenue growth stock have zack rank buy petm express inc pet free report adjust earning share cent second quarter fiscal be year quarter also earning surpass zack consensus estimate stock sport zack rank strong buy see complete list today zack rank stock here wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
180,CAH,intuitive surgical inc isrg free report first quarter result expect release apr market close be expect show steady growth instrument accessory segment revenue other segment be also expect help company generate solid result last quarter company post adjust earning share beating zack consensus estimate revenue totale also outpaced zack consensus estimate first quarter zack consensus estimate revenue be pin indicate year year increase consensus estimate earning be reflect year year rise intuitive surgical deliver positive earning surprise past quarters average be let delve deeper instrument accessory instrument accessory segment deliver solid result last quarter accounting total revenue company flagship da vinci surgical system continue be revenue driver segment first quarter zack consensus estimate revenue be peg show rise year year intuitive surgical inc price consensus intuitive surgical inc price consensus intuitive surgical inc quotein company have introduce da vinci xi surgical system response customer need fourth quarter da vinci install base grow year year unit fact company ship da vinci system fourth quarter compare prior year period company also submit da vinci xi sp platform same quarter other factor intuitive surgical anticipate full year procedure growth solid forecast indicate company release encourage number first quarter well procedure growth be expect be drive general surgery procedure outside unite state management expect operate expense rise company continue invest emerge market new technology include computer assist surgery gross margin be expect net revenue global surgical gain significantly ce mark approval da vinci europe increase use da vinci general surgery unite state continue growth neurology europe japan multispecialty growth korea china also contribute rally additionally fourth quarter ministry health japan list reimbursement procedure quarter revenue outside unite state increase sequentially year year basis surgical be currently face stiff competition niche space regulatory approval transenterix surgical robot abdominal surgery last october competition intuitive surgical have intensified moreover medtech giant medtronic pose threat be possibly work launch surgical robot year here be quantitative model predict intuitive surgical carry zack rank hold do not have positive earning esp need increase odd earning beat zack esp earning esp intuitive surgical be uncover best stock buy sell re report earning esp filter zack rank intuitive surgical carry zack rank increase predictive power esp however also need positive esp be confident earning beat stock worth lookhere be few medical stock worth consider have right combination element post earning beat quarter bio rad laboratory bio free report have earning esp zack rank strong buy see complete list today zack rank stock here cardinal heath cah free report have earning esp zack rank buy abbott laboratory free report have earning esp zack rank investor alert breakthrough pendinga medical advance be now flashpoint theory realization billion dollar research have pour company be already generate substantial revenue even more wondrous product be pipeline cure variety deadly disease be sight so be big potential profit early investor zack name stock buy now click here see
181,CAH,have be month last earning report cardinal health inc cah free report share have add time frame recent positive trend continue lead next earning release be cah due pullback dive investor analyst have react late let take quick look most recent earning report order get better handle important catalyst recent health report third quarter fiscal adjust earning share miss zack consensus estimate adjust earning fall year year revenue increase year year basis almost edge past zack consensus estimate segmental revenue increase year year basis segment witness strong growth specialty business gain large number pharmaceutical distribution customer however segment witness expiration large mail order customer contract divestiture company china distribution business pharmaceutical witness decline profit thank generic pharmaceutical pricing medical segmentrevenue segment improve primarily higher contribution new exist customer acquisition patient recovery business medical segment profit increase margin profit increase year year percentage revenue gross margin expand basis point bps net revenue company slash guidance fiscal adjust earning share downside be cause company effective tax rate associate cordis business have estimate be move then past month investor have witness downward trend fresh estimate have be revision lower current quarter cardinal health inc price consensus cardinal health inc price consensus cardinal health inc quotevgm scorescurrently cah have nice growth score be lag bit momentum front stock be allocate grade value side putt top quintile investment strategy overall stock have aggregate vgm score aren focuse strategy score be be interested base score stock be primarily suitable value investor also be suitable look growth lesser degree momentum outlookestimate have be broadly trend downward stock magnitude revision indicate downward shift surprise cah have zack rank strong sell expect average return stock next few month
182,CAH,buzz obamacare affordable care act aca remain persistent capitol hill lukewarm response replacement american health care act ahca have force republican continue seek new avenue bid save face trump administration attempt skinny repeal bill fail make headway senate go ahead believe impasse be slate continue president trump have always be outspoken critic aca apprehension come uncertainty regard outcome slew event include possibility rate hike fed stronger dollar debate fate cadillac tax excise tax high cost healthcare plan stance healthcare insurance company aca be expect spark bout volatility add factor be effect hurricane harvey bourse reason be worry investor uncertainty find investment option be not perturbed market gyration be tough decision dividend investing rescuea evident medtech story stock be volatile be risky time uncertainty ruling market be not surprising dividend investing have emerge most popular investing theme dividend stock be always investor prefer choice provide steady income cushion market risk stock be generally less volatile nature hence be dependable come long term investment plan not only offer higher income current environment rate remain low expect hike also provide relief adverse market condition dividend stock be safe bet create wealth payout generally act hedge economic uncertainty simultaneously provide downside protection offer sizable yield regular basis pick best stock benefit dividend investing be stress enough keep mind not company keep dividend pay momentum hence investor need be cautious order select best stock potential steady return have used zack stock screener narrow stock offer decent dividend yield have market cap more see complete list today zack rank strong buy stock here choicesabbott laboratory free report abbott park il base abbott laboratory discover develop manufacture sell diversify line health care product company also have large pharmaceutical business be major player nutritional diagnostic market abbott generate revenue company dividend currently yield year historical dividend growth rate be cardinal health inc cah free report headquarter dublin cardinal health inc be nation wide drug distributor provider service pharmacy healthcare provider manufacturer company have report segment pharmaceutical medical company generate revenue excess last report fiscal cardinal health dividend currently yield year historical dividend growth rate be patterson company inc pdco free report headquarter st paul mn patterson company be lead distributor dental animal health product company distribute product mainly subsidiary patterson dental patterson animal health report revenue fiscal company dividend currently yield year historical dividend growth rate be owen minor inc omi free report base mechanicsville va owen minor be global healthcare service company focuse provide supply chain service healthcare provider manufacturer healthcare product company provide logistic service spectrum medical product disposable medical supply device implant company generate revenue excess last report fiscal company dividend currently yield year historical dividend growth rate be bottom lineamid unpredictable medtech set investing high yielding dividend stock fetch promising return more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
183,CAH,have be more month last earning report cardinal health inc cah free report share have lose time frame underperform market recent negative trend continue lead stock next earning release be due dive investor analyst have react late let take quick look most recent earning report order get better handle important catalyst recent health inc report fourth quarter fiscal adjust earning share beat zack consensus estimate increase year year basis revenue increase year year basis almost beating zack consensus estimate quarter segment pharmaceutical revenue rise year year basis segment witness strong growth specialty business also gain huge number pharmaceutical distribution customer however generic pharmaceutical pricing company recent investment pharmaceutical platform lead drop segmental profit however solid performance red oak sourcing platform have partially offset negative effect medical segment revenue segment increase primarily higher contribution new exist customer medical segment profit increase courtesy higher contribution new exist customer solid performance post acute segment however unfavorable performance cardinal health brand product include cordis partially offset sale segment other detail distribution selling general administrative sg expense increase year year basis report quarter cash equivalent be jun fy fiscal cardinal health register adjust earning share year year basis revenue increase year year basis record delve deeper segmental revenue detail pharmaceutical segment net revenue increase fiscal medical segment net revenue revenue soar year year basis company issue fiscal guidance adjust earning share continue operation furthermore cardinal health be expect register fiscal adjust earning share least have estimate be move then follow release investor have witness upward trend fresh estimate have be revision higher current quarter cardinal health inc price consensus cardinal health inc price consensus cardinal health inc quotevgm scoresat time cardinal health stock have nice growth score be lag bit momentum front charting somewhat similar path stock be allocate grade value side putt top investment strategy overall stock have aggregate vgm score aren focuse strategy score be be interested base score stock be more suitable value investor look growth lesser degree momentum outlookwhile estimate have be broadly trend upward stock magnitude revision have be net stock have zack rank sell be expect average return stock next few month
184,CAH,stock market witness choppy session thursday initial hour trading index enter negative territory however index re-cover most loss rest trading session finally nasdaq composite end red dow manage gain marginally uncertainty fed future plan concern regard impending trade war weak earning result fuel market volatility dow jone industrial average dji close increase marginal point however index inx decrease close nasdaq composite index ixic close also decrease total share be trade thursday higher last session average share decliner outnumber advancer nyse ratio nasdaq decliner have edge advancer ratio cboe vix decrease close touch nearly early hour trading be biggest day jump wall street fear index april do benchmark perform dow gain point end trading reverse spate loss suffer last successive session however blue chip index be point early hour trading fall day move average finally index re-cover loss close psychological barrier notably stock index close red trade green decrease lead decline healthcare select sector spdr xlv financial select sector spdr xlf notably sector benchmark index end negative territory initial hour trading benchmark index be much breaking day move average index re-cover most lose ground still close red nasdaq composite lose drop more trading session strong performance large cap tech stock help tech laden index make most loss final hour trading uncertainty regard fed policy inflation touch fed target level market be expect strategy central bank central bank raise magnitude benchmark interest rate increase number interest rate hike also speed wind bond purchase further however central bank do not provide clear cut indication future monetary policy recently conclude meeting industry watcher economist be divide fed future move regard pace rate increase higher interest rate raise cost fund corporate individual strengthen dollar affect export trade war fear loom largetrade war fear remain heighten even high level delegation lead treasury secretary steven mnuchin meet chinese counterpart week negotiate trade related dispute meanwhile president trump be contemplate issue executive order restrict select chinese equipment maker selling product unite state weak earning result thursday several large company post weak earning result otherwise extremely strong first quarter earning session share american international group inc aig free report plummet report first quarter operate earning share miss zack consensus estimate read more share cardinal health inc cah free report plunge report third quarter fiscal adjust earning share miss zack consensus estimate read more share tesla inc tsla free report drop chief executive officer elon musk attack medium earning conference call cut analyst ask company profit potential margin tesla incur adjust loss share first quarter narrower zack consensus estimate loss read more economic institute supply management ism report manufacturing sector decline april march read consensus estimate april read be however service sector maintain month streak overall expansion decline april read mean service be expand department labor report worker productivity increase annualize rate first quarter read be lower consensus estimate be better read fourth quarter meanwhile jobless claim unemployment benefit rise seasonally adjust week end april fall lowest level be better consensus estimate department labor also report unit labor cost increase first quarter figure be better consensus estimate be well fourth quarter read factory order month march increase beating consensus estimate read february be revise increase prior read commerce department report trade deficit drop march lowest level september march datum reversed straight monthly increase trade deficit however figure be consensus estimate decline stock make headlineworld wrestling earning surpass revenue missworld wrestling entertainment inc wwe free report post first quarter adjust earning share beat zack consensus estimate read more today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
185,CAH,cardinal health inc cah free report be healthcare service company engage provide pharmaceutical medical product service unite state international market company primarily operate segment pharmaceutical medical currently cardinal health have zack rank hold change follow fourth quarter fiscal earning report have just release see complete list today zack rank strong buy stock here have highlighted key detail just release announcement earning cardinal health adjust earning rise year year basis share also outpaced zack consensus estimate revenue revenue increase year year basis almost beating zack consensus estimate cardinal health inc price ep surprise cardinal health inc price ep surprise cardinal health inc quotekey stat pharmaceutical revenue surge revenue medical segment increase quarter pharmaceutical segment revenue increase due strong growth specialty business higher number pharmaceutical distribution business customer higher contribution net new exist customer solid performance post acute segment be primarily responsible growth medical segment revenue company expect adjust earning fiscal range share check back later full cardinal health earning report later more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
186,CAH,share dynavax technology corp dvax free report jump food drug administration advisory committee announce safety datum hepatitis vaccine aid approvalshare scripps network interactive inc rise enter agreement discovery communication inc disca free report be buy cash stock amount sharemedtronic mdt free report complete sale part patient monitoring recovery division cardinal health cah free report cash deallabcorp lh free report enter agreement buy chiltren international limit whopping cash
187,CAH,value investing be easily most popular way find great stock market environment wouldn want find stock be fly radar be compelling buy offer tantalize discount compare fair value way find company be look several key metric financial ratio many be crucial value stock selection process let put cardinal health inc cah free report stock equation find be good choice value oriented investor right now investor subscribe methodology look elsewhere top pick pe ratioa key metric value investor always look be price earning ratio pe short show much investor be willing pay dollar earning give stock be easily most popular financial ratio world best use pe ratio be compare stock current pe ratio ratio have be past compare average industry sector compare market whole front cardinal health have trail month pe ratio see chart level actually compare pretty favorably market large pe stand focus stock long term pe trend current level put cardinal health current pe ratio midpoint past year further stock pe also compare favorably industry trail month pe ratio stand very least indicate stock be relatively undervalue right now compare peer also point cardinal health have forward pe ratio price relative year earning just so be fair say slightly more value oriented path be ahead cardinal health stock term too ratioanother key metric note be price sale ratio approach compare give stock price total sale lower read be generally consider better person metric more other value focuse one look sale something be far harder manipulate accounting trick earning right now cardinal health have ratio be much lower average come right now also see chart be high stock particular past few year broad value outlookin aggregate cardinal health currently have zack value style score putt top stock cover look make cardinal health solid choice value investor stock overall cardinal health be good choice value investor be plenty other factor consider investing name particular be worth note company have growth grade momentum score give cah zack vgm score overarch fundamental grade read more zack style score here meanwhile company recent earning estimate have be mixed best current quarter have see estimate go higher past day compare lower full year estimate have see same time period have impact consensus estimate current quarter consensus estimate have fall past month full year estimate have inched higher see consensus estimate trend recent price action stock chart cardinal health inc price consensus cardinal health inc price consensus cardinal health inc somewhat mixed trend be stock have just zack rank hold be look line performance company term bottom linecardinal health be inspire choice value investor be hard beat incredible lineup statistic front however sluggish industry rank bottom zack rank be hard get too excited company overall fact past year industry have clearly underperform broader market see so value investor want analyst sentiment broader factor turn name first once happen stock be compelling pick hacker put money portfolio earlier month credit bureau equifax announce massive datum breach affect american cybersecurity industry be expand quickly response similar event stock be better investment other zack have just release cybersecurity investor guide help zack com reader make most year investment opportunity create hacker other threat reveal stock worth look right away download new report now
188,CAH,cardinal health inc cah free report report third quarter fiscal adjust earning share miss zack consensus estimate adjust earning fall year year revenue increase year year basis almost edge past zack consensus estimate cardinal health have zack rank hold last month share cardinal health have outperformed industry stock have return industry rise segmental revenue increase year year basis segment witness strong growth specialty business gain large number pharmaceutical distribution customer however segment witness expiration large mail order customer contract divestiture company china distribution business pharmaceutical witness decline profit thank generic pharmaceutical pricing medical segmentrevenue segment improve primarily higher contribution new exist customer acquisition patient recovery business medical segment profit increase cardinal health inc price consensus ep surprise cardinal health inc price consensus ep surprise cardinal health inc quotemargin profit increase year year percentage revenue gross margin expand basis point bps net revenue company slash guidance fiscal adjust earning share current range be significantly lower previous estimate downside be cause company effective tax rate associate cordis business zack consensus estimate revenue be peg takecardinal health exit quarter tepid note adjust earning miss consensus mark company witness encourage performance medical segment pharmaceutical segment register strong growth specialty business gain large number pharmaceutical distribution customer further company be banking strategic buyout joint venture supply agreement drive growth growth business profit pharmaceutical segment be hurt generic pharmaceutical pricing huge investment pharmaceutical platform lackluster generic performance be likely mar cardinal health operational efficiency upcoming quarters intense competition customer concentration be other bottleneck recently company close divestiture cardinal health china distribution earning medtech major glancea few better rank stock broader medical space report solid earning season be baxter international inc bax free report varian medical system inc var free report intuitive surgical inc isrg free report intuitive surgical varian sport zack rank strong buy baxter carry zack rank buy see complete list today zack rank stock here intuitive surgical report adjust earning share surpass zack consensus estimate revenue totale beat zack consensus estimate varian report second quarter fiscal adjust earning share beat zack consensus estimate adjust earning improve year year basis baxter report first quarter adjust earning share cent beat zack consensus estimate improve year quarter figure cent medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
189,CAH,cardinal health cah free report be healthcare service company engage provide pharmaceutical medical product service unite state international market company primarily operate segment pharmaceutical medical currently cardinal health have zack rank hold change follow third quarter fiscal earning report have just release see complete list today zack rank strong buy stock here have highlighted key detail just release announcement earning cardinal health adjust earning decrease year year basis share notably figure miss zack consensus estimate revenue revenue increase year year basis almost edge past zack consensus estimate key stat pharmaceutical revenue surge revenue medical segment increase report quarter pharmaceutical segment revenue increase due strong growth specialty business higher number pharmaceutical distribution business customer growth medical segment be be drive contribution acquisition patient recovery business cardinal health inc price ep surprise cardinal health inc price ep surprise cardinal health inc quotemajor factor company reduce guidance fiscal adjust earning share significantly lower previously issue range downside be attribute company effective tax rate associate cordis businessstock price last month share cardinal health have outperformed industry stock return industry gain however follow earning release share price do not show movement pre market trading session check back later full cardinal health earning report later medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
190,CAH,month have go last earning report cardinal health cah free report share have add time frame recent positive trend continue lead next earning release be cah due pullback dive investor analyst have react late let take quick look most recent earning report order get better handle important catalyst recent earningshowever exclude cent benefit legislate tax reform adjust earning come meanwhile adjust earning year quarter be share revenue increase year year basis almost beat zack consensus estimate segmental revenue soar year year basis segment witness strong growth specialty business also gain huge number pharmaceutical distribution customer however segment witness drop profit thank generic pharmaceutical pricing company recent investment pharmaceutical platform lackluster generic program performance however solid performance specialty solution business have partially offset negative effect segment medical segmentrevenue segment increase whopping primarily higher contribution new exist customer medical segment profit increase courtesy higher contribution new exist customer acquisition patient recovery business share repurchase programboard director cardinal health approve new authorization repurchase company common share expire dec latest authorization cardinal health be now authorize repurchase common share marginsas percentage revenue gross margin contract basis point bps net revenue however gross profit quarter be year year distribution selling general administrative sg expense increase year year basis report quarter guidancetaking consideration cent share benefit lower federal rate due tax reform cardinal health raise fiscal outlook company expect adjust earning share continue operation range share higher previously guide range share have estimate be move then past month investor have witness downward trend fresh estimate have be revision higher current quarter compare lower cardinal health price consensus cardinal health price consensus cardinal health quotevgm scoresat time cah have subpar growth score however momentum be do lot better follow exact same course stock be allocate grade value side putt top quintile investment strategy overall stock have aggregate vgm score aren focuse strategy score be be interested zack style score indicate company stock be suitable value momentum investor outlookestimate have be trend downward stock magnitude revision indicate downward shift notably cah have zack rank hold expect line return stock next few month
191,CAH,feb issue update research report cardinal health inc cah free report stock carry zack rank buy company exit second quarter solid note courtesy encourage performance medical segment pharmaceutical segment also witness strong growth specialty business gain large number pharmaceutical distribution customer strong fiscal outlook buoy optimism cardinal health share price movement last year have fail impress stock have lose almost compare unfavorably industry gain cardinal health face risk lose considerable business case loss major customer turn severely impair revenue however company share price have be rise second quarter earning release stock have gain yesterday close cardinal health medical pharmaceutical offering lend company competitive edge niche space company offer industry expertise expand portfolio safe product also cardinal health follow acquisition drive strategy continue focus investment key growth business gain market traction boost profit cardinal health recently announce acquisition medtronic mdt free report patient care deep vein thrombosis nutritional insufficiency business buyout particularly boost company medical segment further cardinal health be pursue growth joint venture long term supply agreement company enter long term strategic agreement henry schein latter purchase cardinal health medical supply physician practice collaboration be expect drive core sale prove accretive cardinal health earning long term growth business profit company pharmaceutical segment be hurt generic pharmaceutical pricing huge investment pharmaceutical platform lackluster generic performance be likely mar cardinal health operational efficiency upcoming quarter intense competition customer concentration be other bottleneck other key picksa couple other top rank stock broader medical sector be perkinelmer pki free report bio rad laboratory bio free report bio rad laboratory have zack rank strong buy see complete list today zack rank stock here company have long term expect earning growth rate perkinelmer have long term expect earning growth rate stock carry zack rank zack top stock addition stock discuss know finest buy hold ticker entirety last year zack top stock portfolio produce double digit winner include fmc corp vmware rac stellar gain now brand new portfolio have be handpick company cover zack rank don miss chance get long term buy access zack top stock today
192,CAH,cardinal health inc cah free report report second quarter fiscal adjust earning share beat zack consensus estimate however exclude cent benefit legislate tax reform adjust earning be share meanwhile adjust earning year quarter be share revenue increase year year basis almost beat zack consensus estimate cardinal health inc price consensus ep surprise cardinal health inc price consensus ep surprise cardinal health inc stock have zack rank buy segmental revenue increase year year basis segment witness strong growth specialty business also gain large number pharmaceutical distribution customer however segment witness decline profit thank generic pharmaceutical pricing recent investment pharmaceutical platform lackluster generic program performance however solid performance specialty solution business partially offset negative impact segment medical segmentrevenue segment improve primarily higher contribution new exist customer medical segment profit increase courtesy higher contribution new exist customer acquisition patient recovery business share repurchase company board director approve new authorization repurchase company common share expire dec latest authorization cardinal health be authorize repurchase common share marginsas percentage revenue gross margin contract basis point bps net revenue however gross profit quarter be year year distribution selling general administrative sg expense increase year year basis benefit cent share lower federal rate due tax reform cardinal health raise fiscal outlook company expect adjust earning share continue operation range share higher previous range takecardinal health exit quarter solid note courtesy encourage performance medical segment pharmaceutical segment witness strong growth specialty business gain large number pharmaceutical distribution customer further company be banking strategic buyout joint venture supply agreement drive growth strong fiscal outlook buoy optimism flip side growth business profit pharmaceutical segment be hurt generic pharmaceutical pricing huge investment pharmaceutical platform lackluster generic performance be likely mar cardinal health operational efficiency upcoming quarter intense competition customer concentration be other bottleneck recently company recently close divestiture cardinal health china distribution other key picksa few other top rank stock report solid result earning season be petm express pet free report perkinelmer pki free report becton dickinson company bdx free report petm sport zack rank strong buy perkinelmer becton dickinson carry zack rank see complete list today zack rank stock here petm report third quarter fiscal result adjust earning share be cent prior year quarter revenue rise year year basis perkinelmer report fourth quarter adjust earning share cent adjust revenue be approximately year quarter becton dickinson report first quarter adjust earning share constant currency revenue totale constant currency make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
193,CAH,feb issue update research report quest diagnostic inc dgx free report major commercial laboratory service provider stock carry zack rank buy share quest diagnostic have outperformed broader industry past year stock have gain broader industry decline be encourage note earning revenue increase year year recently report fourth quarter also company bottom line exceed zack consensus estimate quest diagnostic incorporate price quest diagnostic incorporate price quest diagnostic incorporate quote incidentally quest diagnostic have witness significant growth infectious disease testing prescription drug monitoring wellness business be currently refocusing core diagnostic information service business discipline capital deployment company several new collaboration hospital integrate delivery network continue act major growth driver be look forward company recently close buyout mobile medical examination service national provider home base health risk assessment related service apart guidance look promising indication bullish trend continue later quest diagnostic come upgrade long term growth outlook base new extend point strategy generate shareholder value accelerate growth drive operational excellence company expect revenue growth period earning same time frame be expect better revenue faster rate mid high single digit range company increase number partnership other health care leader be create ample opportunity top bottom line growth simultaneously improve patient experience reduce overall cost care suffering several quarters dull volume company have finally start see improvement term volume pricing however sustainability progress be still doubt further reimbursement wo remain also quest diagnostic be highly disappoint recent cms center medicare medicaid service proposal related protect access medicare act december company key member american clinical laboratory association come forward support lawsuit act secretary department health human service lawsuit charge cms operate hhs purview have fail follow congressional directive implement market base laboratory payment system other stock considera few other top rank stock broader medical space be abiom abmd free report athenahealth athn free report cardinal health cah free report sporting zack rank strong buy see complete list today zack rank stock here abiom have expect long term growth rate stock have soar last month surpass broader industry performance athenahealth have project long term growth rate stock have gain last month ahead industry rise cardinal health have expect long term growth rate last day stock have climb higher industry increase make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
194,CAH,cardinal health cah free report be healthcare service company engage provide pharmaceutical medical product service unite state international market company primarily operate segment pharmaceutical medical currently cardinal health have zack rank buy change follow second quarter fiscal earning report have just release see complete list today zack rank strong buy stock here have highlighted key detail just release announcement earning cardinal health adjust earning increase year year basis share exclude cent benefit tax reform adjust earning share be notably figure outpaced zack consensus estimate cardinal health inc price ep surprise cardinal health inc price ep surprise cardinal health inc quoterevenue revenue increase year year basis almost beating zack consensus estimate key stat pharmaceutical revenue surge revenue medical segment increase report quarter pharmaceutical segment revenue increase due strong growth specialty business higher number pharmaceutical distribution business customer growth medical segment be be drive contribution acquisition patient recovery business major factor company raise guidance fiscal adjust earning share reflect cent share benefit lower federal rate due tax reform stock price last month share cardinal health have outperformed broader industry stock return industry gain however follow earning release share price do not show movement pre market trading session check back later full cardinal health earning report later make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
195,CAH,dublin base cardinal health cah free report global player healthcare service product space be set report fourth quarter fiscal result aug bell company report adjust earning share last report quarter beat zack consensus estimate increase year year basis stock have deliver positive earning surprise past quarters average let take look thing be shape prior fourth quarter earning announcement factor playstrong outlook management cardinal health be bullish significant cash generation fourth quarter furthermore company cordis business be expect generate accretive return quarter note solid commercial momentum global basis cordis segment generate sluggish return last report quarter however fourth quarter cardinal health be expect leverage patient recovery business cordis profile meanwhile cardinal health reaffirm fiscal guidance range adjust earning share continue operation outlook represent growth approximately prior fiscal pricing pressure generic portfolio cardinal health have be grapple pricing deflation generic segment long management reimbursement pressure be likely affect company customer base also impede generic launch term incremental expense specifically pharma segment dent profit fourth quarter cutthroat competition niche space cardinal health face tough competition business segment example pharmaceutical supply chain business face competition mckesson well several smaller medical surgical distributor such henry schein owen minor intensify competition global market be likely mar cardinal health top line fourth quarter estimate revision trend company estimate revision trend lack luster current quarter analyst moved south compare upward revision last month last month current quarter estimate decline almost share add concern cardinal health inc price ep surprise cardinal health inc price ep surprise cardinal health inc quoteearning whispersour proven model do not conclusively show cardinal health be likely beat earning quarter be stock need have positive earning esp zack rank strong buy buy hold beat estimate be not case here see zack esp earning esp cardinal health be most accurate estimate zack consensus estimate be peg uncover best stock buy sell re report earning esp filter zack rank cardinal health currently carry zack rank favorable zack rank increase predictive power esp company unfavorable esp make surprise prediction difficult meanwhile caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision stock warrant lookhere be few company want consider proven model show have right combination element post earning beat quarter genomic health inc ghdx free report have earning esp zack rank see complete list today zack rank stock here halyard health inc have earning esp zack rank pfizer inc pfe free report have earning esp zack rank more stock news company verge apple rundid miss apple stock explosion launch iphone now look be pivotal year get emerge technology expect rock market demand soar almost nothing report suggest save life decade turn save healthcare cost bonus zack special report name breakthrough best stock exploit apple company be already strong coil potential mega gain click see right now
196,CAH,be thick fourth quarter earning season member have report number current earning season have see average proportion positive surprise favorable revision trend present upcoming quarter strong revenue momentum latest earning preview total earning company have report so far be year year higher revenue total beat earning surpass revenue estimate member line release quarterly result week be decidedly bullish equity market be gradually demonstrate sequential improvement medtech earning so farmedical zack sector be expect stand quarter sector benefit favorable consumer behavior grow prevalence minimally invasive surgery demand liquid biopsy test use ensure quick improve patient care shift payment system value base model be evident result medtech heavyweight laboratory corporation america holding lh free report labcorp becton dickinson company bdx free report company end fourth quarter solid note earning beating zack consensus estimate upbeat fy guidance also instill confidence regard labcorp adjust ep guidance be range further becton dickinson company expect adjust earning share band previous fourth quarter expect earning growth rate sector be revenue growth cah holx see stronger earning let take look major medtech stock cardinal health cah free report hologic inc holx free report slate release quarterly report feb cardinal health be schedule release result market open notably zack consensus estimate second quarter fiscal revenue be peg year year diverse product portfolio cardinal health be largest distributor pharmaceutical medical supply however zack consensus estimate second quarter earning be peg year year company face risk lose considerable business case loss major customer severely impair bottom line fact cardinal health announce loss large mail order customer prime therapeutic dent revenue company specialty pharmaceutical distribution segment last quarter cardinal health inc price ep surprise cardinal health inc price ep surprise cardinal health inc quotemoreover quantitative model do not conclusively show beat cardinal health be stock need have positive earning esp zack rank strong buy buy hold be able beat estimate cardinal health have zack rank earning esp uncover best stock buy sell re report earning esp filter read more store cardinal health earning hologic be set report first quarter fiscal result market close notably zack consensus estimate earning be cent year year basis diagnostic segment be expect record revenue year quarter also zack consensus estimate show decline year year be blame estimate loss divest blood screening franchise also company have be see weak sale cytology perinatal product late bright side zack consensus estimate first quarter revenue be peg year year company be expect see stellar performance molecular diagnostic major sub segment diagnostic unite state company be expect gain expand market utilization fully automate panther system hologic inc price ep surprise hologic inc price ep surprise hologic inc quoteour quantitative model indicate earning beat hologic quarter have favorable combination earning esp zack rank see complete list today zack rank stock here zack top stock addition stock discuss know finest buy hold ticker entirety last year zack top stock portfolio produce double digit winner include fmc corp vmware rac stellar gain now brand new portfolio have be handpick company cover zack rank don miss chance get long term buy access zack top stock today
197,CAH,feb issue update research report lead medical device company boston scientific corporation bsx free report stock carry zack rank hold notably house senate decision suspend medical device tax year have come breath fresh air medical device mammoth boston scientific company temporary suspension turn allow continue plan investing innovative medical product meanwhile company be intent work complete repeal medtech tax be also encourage boston scientific major investment santa rosa base millipede move be expect consolidate company position grow field mitral regurgitation mr fall structural heart business millipede be developer iris transcatheter annuloplasty ring system treatment severe mr positive note product claim be highly customizable specific patient anatomy disease state apart gradually improve foreign exchange scenario have start contribute company overall top line performance promising view be also impressive flip side decline worldwide pacemaker sale recent past continue weigh boston scientific crm customer relationship management result fourth quarter company witness high single digit decline pacemaker performance due tough comparison draw stronger revenue reap launch company brady mri linepost april late company have take several measure rebound trend term outlook still look bleak additionally fate lotus valve issue seem limbo more time boston scientific recently company announce further delay earlier report timeline commercial return lotus edge aortic valve system europe unite state follow product voluntary recall last february sync downtrend boston scientific have be trading broader industry past month stock have lose compare broader industry rise period key picksa few better rank stock broader medical space be abiom abmd free report athenahealth athn free report cardinal health cah free report sporting zack rank strong buy see complete list today zack rank stock here abiom have expect long term growth rate stock have soar last month surpass broader industry performance athenahealth have project long term growth rate stock have increase last month industry gain cardinal health have estimate long term growth rate last month stock have gain higher industry growth more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
198,CAH,cardinal health cah free report be set report second quarter fiscal result feb close bell company innovative product line strategic buyout joint venture supply agreement indicate significant long term opportunity last quarter cardinal health adjust earning decline year year basis share however figure beat zack consensus estimate revenue inched year year basis almost miss zack consensus estimate stock deliver positive earning surprise trail quarters average beat be recent development cardinal health close acquisition medtronic mdt patient recovery business cash further company launch connectsource new cloud base patient engagement platform be likely drive top line second quarter cardinal health inc price consensus cardinal health inc price consensus cardinal health inc quotelet take look thing be shape prior second quarter earning announcement cushion macroeconomic sluggishness large cap diversify healthcare distributor such cardinal health be cushion macroeconomic uncertainty political riddle cardinal health be largest distributor pharmaceutical medical supply have diverse product portfolio be hedge risk probable sale shortfall macroeconomic slow fact company have long term expect earning growth rate view tepid zack consensus estimate second quarter earning be peg year year basis company face risk lose considerable business case loss major customer severely impair bottom line fact cardinal health announce loss large mail order customer prime therapeutic dent company specialty pharmaceutical distribution revenue last quarter meanwhile zack consensus estimate second quarter revenue be year year pricing pressure generic portfolio cardinal health have be grapple pricing deflation generic segment management reimbursement pressure be likely affect company customer base also impede generic launch term rise expense specifically pharma segment dent profit second quarter cutthroat competition niche space cardinal health witness tough competition business segment instance pharmaceutical supply chain business face competition several smaller medical surgical distributor intense competition global market be likely mar cardinal health top line second quarter earning whispersour proven model do not conclusively show cardinal health be likely beat earning quarter be stock need have positive earning zack rank strong buy buy hold beat estimate be not case here see zack esp earning esp cardinal health be uncover best stock buy sell re report earning esp filter zack rank cardinal health carry zack rank notably caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision stock warrant lookhere be few other medical stock worth consider have right combination element post earning beat quarter amphastar pharmaceutical amph free report have earning esp zack rank see complete list today zack rank stock here anthera pharmaceutical anth free report have earning esp zack rank fibrocell science fcsc free report have earning esp zack rank don even think buy bitcoin read most popular cryptocurrency sky-rocket last year give investor chance bank return even more gain however come serious volatility risk bitcoin sank more time zack have just release new special report help reader capitalize explosive profit potential bitcoin other cryptocurrency significantly less volatility buy directly see crypto related stock now
199,CAH,putt end speculation amazon com inc amzn free report have finally step high potential pharmaceutical industry line online retail behemoth recently announce definitive acquisition agreement pillpack term deal have be keep wrapped few market expert estimate value transaction news be heavily cheer investor send amazon share price higher day announcement do amazon entry spell doom pharmacy amazon entry pharmacy business be well speculate still come shocker industry bigwig let take closer look reaction behemoth amazon com inc price amazon com inc price amazon com inc quotebegin walgreen boot alliance inc wba free report have be bask glory be add youngest member dow jone industrial average index see decline stock price day buyout announcement company also see rating downgrade number analyst walgreen boot alliance inc price walgreen boot alliance inc price walgreen boot alliance inc stock other big retailer rite aid corporation rad free report cvs health corporation cvs free report also slip same day cvs health corporation price cvs health corporation price cvs health corporation quoteper report bigwig collectively lose market value day rite aid corporation price rite aid corporation price rite aid corporation quotemajor drug distributor cardinal health inc cah free report corporation abc free report mckesson corporation mck free report also panic stock fall respective rational be deal amazon era brick mortar set up be be challenged online seller amazon entry prescription drug industry be welcome news consumer be also fraught challenge come back buyout pillpack be online pharmacy pre sort medication different dose handle refill renewal also hold pharmacy license state have urac vipps accreditation be network pharmacy most pharmacy benefit manager pbms major medicare part plan article stat integration pillpack help amazon become major player drug business analyst believe pillpack be work medicare plan amazon be able see increase amazon prime membership rapidly grow age group be high chance prime subscriber amazon choose company prescription drug need however deal have come own set challenge article publish pymnt com pillpack source product walgreen boot further same article be rumor recent past walgreen boot plan buy pit walgreen boot amazon space pillpack network membership express script be also subject renewal end july be be speculate amazon appear be formidable threat pbms start refrain renew network membership future article publish pymnt com regard amazon have let go stake drugstore com pbms deny include drugstore com network eventually result drugstore com exit prescription business article publish axio bad be news pharmaceutical giant ve get keep reinvent ll have new competitor ll have new customer nothing more aptly sum situation remark ginni rometty ibm ceo incumbent player drugstore industry don seem be mood give lose turf counter competition cvs health walgreen boot other have start add more digital customer friendly program company have incorporate mail order pharmacy model store same day day day delivery program further cvs health deal unite state third largest health insurance company aetna fortify position industry bid ensure availability specialty brand drug walgreen boot have tie express script have announce plan expand exist group purchasing effort report walgreen boot be also collaborate number healthcare business include health insurer humana unitedhealth group company be also partner lab testing provider laboratory corporation america holding expand range health service store further analyst believe prefer cash payment be expect opt more amazon pharmacy service percentage population be quite nominal moreover patient need immediate drug approach store wait online delivery consider factor major analyst believe be enough scope left behemoth maintain competitive edge space sum upamazon entry have definitely create upheaval prescription drug industry major player struggle keep afloat however business bankable human resource strong financial position matter most amazon have adequate amount so follow quote neil saunder manage director globaldata retail reuter suitably sum current scenario amazon acquisition pillpack be warning shot be become major battle pharmacy space today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
200,CAH,cardinal health inc cah free report clayton dubilier rice cd recently announce joint investment plan navihealth notably tennessee base navihealth be acquire cardinal health deal value company have goal acquire entire business year navihealth currently serve more insure member manage care transition approximately acute hospital post acute care facility unite state meanwhile cd be oldest private equity firm world specialize buyout growth capital financing post announcement share cardinal health inched close however stock have decline industry increase past month stock currently carry zack rank strong sell come back news cd manage fund acquire approximately ownership stake navihealth cardinal health retain roughly interest business additionally cardinal health reserve call right reacquire business transaction be expect be complete third quarter latest strategic move enable ohio base distributor healthcare service deliver improve post acute care unite state market prospectsper frost sullivan post acute healthcare industry expect surge approximately revenue upside be attributable shift medically complex patient post acute care setting hence be conclude cardinal health decision have be timely strategic cardinal health acute patient health offer broad range acute patient care solution previously acquire navihealth coordinate care acute post acute set apart enable provider customize patient specific care plan company also analyze datum discover pattern optimize workflow furthermore cardinal health outpatient pharmacy solution enable healthcare provider boost patient population health management play critical role continue patient care discharge hospital home company have also launch line cardinal health hospital quality home consumer product allow patient caregiver buy same product used hospital support continuity care list include product related bath safety daily live aids key pickssome better rank stock broader medical space be abiom inc abmd free report stryker corporation syk free report intuitive surgical inc isrg free report abiom have project long term earning growth rate stock sport zack rank strong buy see complete list today zack rank stock here stryker have project long term earning growth rate stock carry zack rank buy intuitive surgical have expect long term earning growth rate zack rank wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
201,CAH,cardinal health inc cah free report be healthcare service company engage provide pharmaceutical medical product service unite state international market company primarily operate segment pharmaceutical medical currently cardinal health have zack rank sell change follow first quarter fiscal earning report have just release see complete list today zack rank strong buy stock here have highlighted key detail just release announcement earning cardinal health adjust earning decrease year year basis share however outpaced zack consensus estimate revenue revenue increase year year basis almost miss zack consensus estimate cardinal health inc price consensus cardinal health inc price consensus cardinal health inc quotekey stat pharmaceutical revenue surge revenue medical segment increase quarter pharmaceutical segment revenue increase due strong growth specialty business higher number pharmaceutical distribution business customer higher contribution net new exist customer acquisition be responsible growth medical segment revenue report quarter cardinal health close acquisition medtronic patient recovery business launch connectsource new cloud base patient engagement platform company expect adjust earning fiscal range share check back later full cardinal health earning report later wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
202,CAH,cardinal health cah free report global player healthcare service product space be set report first quarter fiscal result nov close bell company report adjust earning share last report quarter beat zack consensus estimate increase year year basis stock deliver positive earning surprise trail quarters average beat let take look thing be shape prior fourth quarter earning announcement factor playstrong outlook management cardinal health be bullish significant cash generation first quarter furthermore company cordis business be expect generate accretive return quarter review note solid commercial momentum global basis cordis segment generate sluggish return last report quarter however first quarter cardinal health be expect leverage patient recovery business cordis profile meanwhile cardinal health affirm fiscal guidance adjust earning share continue operation outlook represent growth approximately prior fiscal pricing pressure generic portfolio cardinal health have be grapple pricing deflation generic segment long management reimbursement pressure be likely affect company customer base also impede generic launch term incremental expense specifically pharma segment dent profit first quarter cutthroat competition niche space cardinal health witness tough competition business segment example pharmaceutical supply chain business face competition several smaller medical surgical distributor intensify competition global market be likely mar cardinal health top line first quarter estimate revision trend company estimate revision trend lack luster current quarter analyst moved south compare upward revision last month last month current quarter estimate decline almost share add concern earning whispersour proven model do not conclusively show cardinal health be likely beat earning quarter be stock need have positive earning esp zack rank strong buy buy hold beat estimate be not case here see zack esp earning esp cardinal health be most accurate estimate zack consensus estimate be peg uncover best stock buy sell re report earning esp filter zack rank cardinal health currently carry zack rank sell caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision cardinal health inc price ep surprise cardinal health inc price ep surprise cardinal health inc quotestock warrant look here be few company want consider proven model show have right combination element post earning beat quarter inc research holding inc have earning esp carry zack rank see complete list today zack rank stock here medpace holding inc medp free report have earning esp carry zack rank henry schein inc hsic free report have earning esp carry zack rank today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
203,CAH,cardinal health inc cah free report underperform industry year time company share have lose compare unfavorably industry increase current return be also lower index rise recently cardinal health have be face sluggishness exam glove unit further cutthroat competition niche space be headwind zack consensus estimate bottom line decline last month show year year decline current quarter zack consensus estimate bottom linedecline last month cent indicate fall year year basis cardinal health inc price consensus cardinal health inc price consensus cardinal health inc stock have zack rank strong sell here take peek major issue plague cardinal health issue medical glove unitcardinal health offer robust portfolio medical glove include surgical glove exam glove clean room glove medical segment have be perform well recent quarters company have be face challenge exam glove sub segment third quarter fiscal commodity pricing supply disruption have dampen section fiscal lower expectation medical segment due headwind exam glove segment be concern however company sourcing commercial team be pursue several project minimize impact cordis unit lack lustercardinal health take johnson johnson cordis unit enhance top line performance end third quarter fiscal thing have not be very bright cardinal health especially cordis unit cordis performance not only reduce company adjust operate earning create higher expect adjust effective tax rate cent cordis related increase tax rate be cent take consideration cardinal health anticipate obstacle challenge fiscal management prospect patient recovery red oak subsequent tax reform company face significant headwind include cordis performance customer repricing loss pharmerica continue generic deflation consequently cardinal health be not expect achieve margin rate second half fiscal cutthroat competition niche spacecardinal health face tough competition business segment example pharmaceutical supply chain business face competition mckesson well several smaller medical surgical distributor such henry schein owen minor moreover medical device market be mature whencompare cardinal health pharmaceutical business believe grow competition hurt cardinal health medical segment margin term key pickssome better rank stock broader medical space be abiom inc abmd free report genomic health inc ghdx free report intuitive surgical isrg free report abiom have estimate long term earning growth rate stock sport zack rank strong buy see complete list today zack rank stock here genomic health have expect earning growth rate stock flaunt zack rank intuitive surgical have expect long term earning growth rate sport zack rank today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
204,CAH,old adage sell go away rest historical run be not entirely true go recent year datum article publish cnn com proverb prove wrong past few year october period turn pretty profitable maintain steady trend too witness decent performance raft geopolitical tension index have gain past month dow jone industrial average have add nasdaq composite have score solid gain key event month be packed global event more less impact wall street too be italy political crisis spark fear region leave eurozone tension subside end oil price be roller coaster ride thank push pull oppose force be fear rise output saudi russia other be report lower expect crude inventory build sanction iran venezuela then be uncertainty diplomatic ty north korea unite state trump first pull schedule june meeting north korea kim jong cite north korea tremendous anger open hostility washington north korea expressed keenness resolve issue effort retrieve cancele summit duo be launch jostle weigh broader stock market trade tension flare china unite state latter announce levy tariff worth good china impose new limit chinese investment unite state trump also plan restriction import steel aluminum europe development home be upbeat president trump announce drug plan be line best interest drug maker deregulation banking sector especially ease rule smaller financial institution several economic datum also come better other develop economy backdrop several sector stock come upbeat many have fall apart so be intriguing know stock gain one lose gainer have highlighted stock gain more last week stock have zack rank strong buy buy hold evolus inc eol free report be medical aesthetic company focus provide physician patient aesthetic procedure treatment stock have zack rank turtle beach corporation hear free report zack rank company be audio technology company design audio product consumer commercial healthcare market transenterix inc trxc free report zack rank company design manufacture medical device loser here highlight few stock have zack rank sell strong sell stock be deep red past week avon product inc avp free report be lead global beauty company have zack rank symantec corporation symc free report be world lead cyber security company zack rank cardinal health inc cah free report zack rank company be global integrate healthcare service product company make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
205,CAH,similar wise buy decision exit certain underperformer right time help maximize portfolio return selling loser be difficult share price estimate be fall be time get rid security more loss hit portfolio such stock want consider drop be cardinal health inc cah free report have witness significant price decline past week have see negative earning estimate revision current quarter current year zack rank strong sell further confirm weakness cah key reason move have be negative trend earning estimate revision full year have see estimate move past day compare upward revision trend have cause consensus estimate trend lower go share month current level also current quarter cardinal health have see downward estimate revision versus revision opposite direction drag consensus estimate share past day stock also have see pretty dismal trading lately share price have drop past month cardinal health inc price consensus cardinal health inc price consensus cardinal health inc quote so not be good decision keep stock portfolio anymore least don have long time horizon be still interested medical sector instead consider better rank stock cooper company inc coo free report stock currently hold zack rank buy be better selection time see complete list today zack rank strong buy stock here more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
206,CAH,president donald trump friday unveil plan lower drug price keep promise make run presidential election pharmaceutical company broader industry have be anticipate trump come heavily have long criticize drugmaker get away murder charge way too much product however fear be dispel trump proposal actually not directly hamper profitability drug company instead reform be aim increase competition medicine cut list price reduce patient pocket cost pleasant surprise give stock pharmaceutical company boost long standing drug price be trump presidential campaign promise have commit take big drug company be also support trump democrat opponent hillary clinton then trump have time again criticize drug manufacture pharmaceutical company charge too much product have keep pharmaceutical company reel pressure quite time have fear trump pharma plan hurt profit broader pharma sector spdr pharmaceutical xph have decline year date industry have fear further loss apprehend harsh measure trump friday raise competition twist tale come trump stress increase competition medicine be highpoint speech friday frame plan most sweeping action history lower price prescription drug american person describe american patient first layer policy intend increase pharmaceutical competition power negotiation lower patient pocket cost trump policy also aim create incentive lower list price prescription drug reform certainly be ray hope american patient rise cost healthcare be nagging concern american patient first plan have immediate action well future opportunity lower pocket cost face patient reduce drug price interestingly trump refrain raise direct medicare price negotiation friday be agenda presidential campaign pharma stock rally trump reformsclearly trump american patient first plan doesn seem be threat pharmaceutical company profit fact be very much line financial interest drugmaker health insurer way hamper profit fear have often result share pharma company take hit last few month finally see bounce back friday sector decline initially friday stock start rally time trump have finished speech share regeneron pharmaceutical inc regn free report increase also share cvs health corporation cvs free report merck co inc mrk free report pfizer inc pfe free report walgreen boot alliance inc wba free report be respectively merck co have zack rank buy see complete list today zack rank strong buy stock here trump spare biggest reason rally be trump plan actually doesn hurt pharmaceutical company fact administration keep place few case extend role drug middleman have be often be blame spiking drug cost trump plan call drug company display price ad restrict gag clause pharmacist proposal come pharmacy pharmacy benefit manager pbm have contract donot allow pharmacist let patient know drug cash counter be cheaper be purchase insurance however trump splan give company new power medicare part program senior get drug coverage allow medicare change list cover drug midyear order push back price hike generic drugsthat donot actually have so much competition lead share healthcare service company mckesson corporation mck free report express script hold company esrx free report corporation abc free report cardinal health inc cah free report rise respectively sum uptrump american patient first come set reform have spark fear pharmaceutical company quite time however fear seem have subside somewhat new plan doesn hurt drugmaker profit see investor confidence finally get reinstate pharma biotech stock rally medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
207,CAH,past few month medical device space have be witness considerable upheaval owing confluence factor have affected fortune medtech bigwig cardinal health inc cah free report dentsply sirona inc xray free report penumbra inc pen free report investment climate medical device major have become increasingly volatile due political potshot capitol hill obamacare be due fact gop be make final push affordable care act repeal bill legislation commonly refer graham cassidy aim convert medicaid premium subsidy dollar block grant structure give freedom spending state past fortnight have witness extensive lobbying graham cassidy bill legislator garner require vote senate trend be expect continue september earlier obamacare assured coverage person pre exist ailment restrict insurer charge base health condition senate bill however allow insurer provide less require coverage state get waiver essential health benefit however change not take effect slash medicaid budget tune almost be medtech position space remain volatile be many stock medtech domain promise growth question now arise pick safe stock various industry medtech space such scenario zack industry classification be broadly group medical sector zack sector further sub divide important area medical instrument medical product medical dental supply screening criteriain article have picked winner aforementioned area have trade higher index past year also base strong fundamental strategic implementation plan execution certain positive catalyst carry huge upside potential high probability outperform index come day stock currently flaunt zack rank strong buy buy vgm score here stand value growth momentum score be weight combination metric such score allow investor eliminate negative aspect stock select favorable one market capitalization be multus billion testify strong liquidity estimate revision trend be significantly positive earning growth expectation be finally industry lower market position call more upside offset further volatility capitol hill medical dental dental supply industry be currently rank fall last week industry have underperform shedding past month index other hand have gain apply zack wisdom space be bullish staar surgical company staa free report monrovia base staar surgical develop manufacture distribute product used ophthalmologist other eye care professional improve correct vision patient suffering refractive condition cataract glaucoma price surge approximately last month zack rank stock be attractive pick earning company be expect grow next year period see complete list today zack rank stock here medical instrument industry be currently rank fall last week industry have underperform register gain only past month index have gain only space be bullish masimo corporation masi free report irvine base masimo develop manufacture market family invasive monitoring system price surge approximately year date zack rank stock be attractive pick earning company be expect grow next year period medical product industry be currently rank fall last week industry have underperform register gain only past month index other hand have rise space be bullish nephew plc snn free report nephew headquarter london be manufacturer distributor advanced medical device sport medicine joint reconstruction trauma wound management area price surge approximately year date zack rank stock be attractive pick earning company be expect grow year make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
208,CAH,here be stock add zack rank strong sell list today airgain inc airg free report be designer engineer antenna product original equipment design manufacturer zack consensus estimate current year earning have be revise downward last day food inc bgs free report be manufacturer seller distributor portfolio shelf stable frozen food household product zack consensus estimate current year earning have be revise downward last day bojangle inc boja free report be developer franchiser limit service restaurant zack consensus estimate current year earning have be revise downward last day cardinal health inc cah free report be integrate healthcare service product company zack consensus estimate current year earning have be revise downward last day maxlinear inc mxl free report be provider radio frequency mixed signal communication transport network application zack consensus estimate current year earning have be revise downward last day view entire zack rank list
209,CAH,here be stock add zack rank strong sell list today apogee enterprise inc apog free report design develop glass product service unite state canada brazil zack consensus estimate current year earning have be revise downward last day bp midstream partner lp bpmp free report own acquire operate develop pipeline other midstream asset zack consensus estimate current year earning have be revise downward last day cardinal health inc cah free report operate integrate healthcare service product company zack consensus estimate current year earning have be revise downward last day duluth holding inc dlth free report sell casual wear workwear accessory man woman duluth trading brand unite state zack consensus estimate current year earning have be revise downward last day edgewell personal care company epc free report manufacture market personal care product wet shave sun skin care feminine care infant care category unite state internationally zack consensus estimate current year earning have be revise downward last day view entire zack rank list
210,CAH,aug issue update research report chesterbrook pa base corporation abc free report world largest pharmaceutical service company company focus provide drug distribution related service reduce health care cost improve patient outcome company currently have zack rank hold have unimpressive run bourse last month trading industry term price performance glimpse share price movement reveal share have lose compare unfavorably decline broader industry unfavorable performance be lead pricing pressure generic drug space lackluster guidance full year expect fiscal revenue growth range significantly lower previous band company expect brand drug inflation range take pharmedium healthcare holding back believe temporary slowdown pharmedium growth mar bottom line come quarters notably company aim boost investment enhance pharmedium qa qc quality assurance quality control system term product quality patient safety lend competitive advantage long haul result bottom line headwind business fiscal lackluster performance hepatitis revenue segment be concern regard witness significant negative revenue impact decline sale segment second quarter revenue improve only quarter have be adverse impact hepatitis segment cutthroat competition niche space be add concern operate highly competitive pharmaceutical distribution related health care service market company primary competitor include cardinal health cah free report mckesson mck free report national generic regional distributor generic industry be face consolidation customer manufacturer globalization increase quality regulatory challenge company also face competition manufacturer chain drugstore specialty distributor packaging health care technology company better rank stock broader medical sector be align technology inc algn free report zack rank strong buy see complete list today zack rank stock here align technology have expect long term adjust earning growth almost stock have add roughly last month trade profit big league trump policy stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
211,CAH,be tough week generic drugmaker see share tumble follow release disappointing second quarter result israel base teva pharmaceutical industry limit teva free report teva not only miss earning revenue expectation company also slash outlook announce cut dividend teva share plunge trading session follow release second quarter result reflect concern company business debt burden trigger few analyst downgrade year date ytd teva have lose value versus decline generic pricing environmenta key reason teva dismal performance be generic pricing erosion sharp decline generic drug price blessing patient be prove be major challenge generic drugmaker well drug distributor second quarter conference call teva say ongoing consolidation customer have lead increase price erosion decrease volume consolidation industry have increase ability negotiate lower price generic drug moreover fda be speeding approval generic drug mean more competition increase price cut decrease volume generic drug be basically cheaper version brand drug have go patent teva say price erosion be second quarter be expect increase high single digit remainder year not just teva be affected tough generic pricing environment corporation abc free report report mixed quarter see share decline trading session follow release third quarter fiscal result company mentioned generic deflation remain headwind be yet ease high single digit be quarters generic deflation be expect remain headwind remainder fiscal range situation continue fiscal well cardinal health inc cah free report too mentioned generic drug pricing be material headwind company pharma distribution business fourth quarter fiscal company expect generic deflation mid single digit fiscal stock focusfollow release teva second quarter result company presence generic market see share decline concern company too be affected generic drug pricing environment company mylan nv myl free report lannett company inc lci free report perrigo company plc prgo free report impax laboratory inc be last trading session week investor be focuse mylan second quarter result include company take generic pricing situation impax perrigo also be report result week mylan perrigo impax be zack rank hold stock lannett be zack rank buy stock see complete list today zack rank strong buy stock here medical generic drug industry yr return medical generic drug industry yr returnin view generic price erosion remain headwind remainder year affect margin generic player fda focuse speeding generic drug approval process market continue witness additional competition escalate generic price erosion trade profit big league trump policiesif stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
212,CAH,cardinal health inc cah free report report fourth quarter fiscal adjust earning share beat zack consensus estimate increase year year basis revenue increase year year basis almost beating zack consensus estimate quarter segment pharmaceutical revenue rise year year basis segment witness strong growth specialty business also gain huge number pharmaceutical distribution customer however generic pharmaceutical pricing company recent investment pharmaceutical platform lead drop segmental profit however solid performance red oak sourcing platform have partially offset negative effect medical segment revenue segment increase primarily higher contribution new exist customer medical segment profit increase courtesy higher contribution new exist customer solid performance post acute segment however unfavorable performance cardinal health brand product include cordis partially offset sale segment other detail distribution selling general administrative sg expense increase year year basis report quarter cash equivalent be jun cardinal health inc price consensus cardinal health inc price consensus cardinal health inc quotefy fiscal cardinal health register adjust earning share year year basis revenue increase year year basis record delve deeper segmental revenue detail pharmaceutical segment net revenue increase fiscal medical segment net revenue revenue soar year year basis company issue fiscal guidance adjust earning share continue operation furthermore cardinal health be expect register fiscal adjust earning share least key picksa few better rank stock broader medical sector be edward lifescience corporation ew free report abiom inc abmd free report fresenius medical care corporation fms free report notably fresenius medical care edward lifescience sport zack rank strong buy abiom have zack rank buy see complete list today zack rank stock here fresenius medical care represent return last year company deliver solid earning surprise last report quarter edward lifescience have long term expect earning growth rate notably stock have year return abiom yielded strong return last year stock have long term expect earning growth rate more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
213,CAH,second quarter earning season have be quite impressive so far member cohort have report result latest earning preview second quarter earning whole be expect rise year year growth revenue medical broader sector zack sector be expect record earning growth quarter jul member sector post impressive earning revenue beat average respectively majority bigwig yet report result next week be crucial decide quarter turn be real game changer sector end quarter sector be anticipate witness earning growth back revenue hike medtech face political political gridlock pullback affordable care act obamacare have be make headline medtech space long such political conundrum capitol hill market watcher keep tab medtech space fraternity worry final trump care plan include medtech tax repeal agenda meanwhile old template plan promise eradicate infamous medical device tax cadillac tax excise tax high cost healthcare plan be not bad deal such hullabaloo question emerge be medical technology player stand gain lose earning season let take look major medical technology bigwig be expect release earning result aug cardinal health inc cah free report dublin base global player healthcare service product space be set report fourth quarter fiscal result bell company report adjust earning share last report quarter beat zack consensus estimate increase year year basis stock have deliver positive earning surprise past quarters average cardinal health be banking acquisition strategic buyout joint venture supply agreement drive growth furthermore growth new exist customer count be likely boost earning management cardinal health be bullish significant cash generation fourth quarter furthermore company cordis business be expect generate accretive return quarter read more cardinal health pull surprise earning model do not conclusively predict beat company give combination zack rank hold earning esp be model stock need have positive earning esp zack rank strong buy buy beat earning simultaneously caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision cardinal health inc price consensus ep surprise cardinal health inc price consensus ep surprise cardinal health inc quotehologic inc holx free report headquarter bedford hologic develop manufacture supply diagnostic medical imaging system surgical product cater healthcare need woman company be slate report third quarter fiscal result close bell last quarter company deliver positive earning surprise notably hologic earning surpass zack consensus estimate past quarters average beat overall third quarter fiscal hologic expect revenue compare prior guidance current zack consensus estimate third quarter revenue be company project range adjust ep be project cent high end previous cent range current zack consensus estimate third quarter adjust ep be peg cent company guide range read more offing hologic earning model do not conclusively predict earning beat company give combination zack rank earning esp uncover best stock buy sell re report earning esp filter hologic inc price ep surprise hologic inc price ep surprise hologic inc quotemasimo corporation masi free report irvine base masimo develop manufacture market family invasive monitoring system company be slate release second quarter result market close last quarter masimo report adjust earning cent share surpass zack consensus estimate cent revenue improve year quarter figure also steer past zack consensus estimate masimo face fierce competition oem distributor medical device bigwig mar top line sluggish hospital capital spending environment be overhang intensify competition peer overdependence third party provider customer concentration risk be major concern model do not conclusively predict beat company give combination zack rank earning esp masimo corporation price ep surprise masimo corporation price ep surprise masimo corporation quotewright medical group wmgi free report base amsterdam netherlands medical group be orthopedic medical device company specialize extremity biologic product company be schedule announce second quarter earning result bell medical report adjust loss cent share first quarter wider zack consensus estimate loss cent however loss narrow cent year year basis net sale first quarter totale be consensus mark pricing pressure continue trouble medical increase cost related product launch re build infrastructure be expect put margin pressure problem associate distributor raise concern well model do not predict earning beat company second quarter be stock have unfavorable combination zack rank earning esp medical group price ep surprise medical group price ep surprise medical group quotewill make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
